(ROOT (S (NP (NP (NNP Diabetes) (NNP Care)) (PP (IN in) (NP (DT the) (NNP Hospital)))) (VP (VBZ has) (VP (VBN been) (VP (VBN revised) (S (VP (TO to) (VP (VB include) (NP (DT a) (NN recommendation) (S (VP (TO to) (VP (VB consider) (S (VP (VBG obtaining) (NP (NP (DT an) (NN A1C)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN risk) (NNS factors))))) (PP (IN for) (NP (NP (JJ undiagnosed) (NN diabetes)) (SBAR (WHNP (WP who)) (S (VP (VBP exhibit) (NP (NN hyperglycemia)) (PP (IN in) (NP (DT the) (NN hospital))))))))))))))))))))) (. .)))
(ROOT (NP (NP (NNP Executive) (NNP Summary)) (: :) (NP (NP (NNPS Standards)) (PP (IN of) (NP (NNP Medical) (NNP Care))) (PP (IN in) (NP (NNP Diabetesd2013) (NNP Current) (NNS criteria))) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NN diabetes) (CD •) (NN A1C)) (JJR >) (JJ =) (CD 6.5) (NN %)))))) (. .)))
(ROOT (NP (NN •) (S (S (VP (TO To) (VP (VB test) (PP (IN for) (NP (NP (NN diabetes)) (CC or) (NP (NNS prediabetes))))))) (, ,) (NP (NP (DT the) (NN A1C)) (, ,) (NP (NNP FPG)) (, ,) (CC or) (NP (JJ 75-g) (JJ 2-h) (NN OGTT))) (VP (VBP are) (ADJP (JJ appropriate)))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (NP (NP (NP (NN Prevention/delay)) (PP (IN of) (NP (NN type) (CD 2) (NN diabetes))) (NP (NP (CD •) (NNS Patients)) (PP (IN with) (NP (NP (JJ impaired) (NP (NN glucose) (NN tolerance)) (PRN (-LRB- -LRB-) (NP (NN IGT)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))))) (, ,) (NP (NP (JJ impaired) (NN fasting) (NN glucose) (-LRB- -LRB-) (NN IFG) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (CC or) (NP (DT an) (NP (NN A1C) (CD 5.7))) (: --) (NP (NP (CD 6.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (SBAR (S (VP (MD should) (VP (VB be) (VP (VBN referred) (PP (TO to) (NP (NP (DT an) (JJ effective) (JJ ongoing) (NN support) (NN program)) (VP (VP (VBG targeting) (NP (NP (NN weight) (NN loss)) (PP (IN of) (NP (NP (CD 7) (NN %)) (PP (IN of) (NP (NN body) (NN weight))))))) (CC and) (VP (VBG increasing) (NP (JJ physical) (NN activity)) (PP (TO to) (NP (NP (NP (QP (IN at) (JJS least) (CD 150)) (NN min/week)) (PP (IN of) (NP (JJ moderate) (NN activity)))) (PP (JJ such) (IN as) (S (VP (VBG walking)))))))))))))))) (. .)))
(ROOT (S (S (NP (NP (NN •) (NN Metformin) (NN therapy)) (PP (IN for) (NP (NP (NN prevention)) (PP (IN of) (NP (NN type) (CD 2) (NN diabetes)))))) (VP (MD may) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT those)) (PP (IN with) (NP (NP (NP (NN IGT)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IFG)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (CC or) (NP (DT an) (NP (NN A1C) (CD 5.7))))))))))) (: --) (NP (NP (NP (CD 6.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (PP (ADVP (RB especially)) (IN for) (NP (NP (DT those)) (PP (IN with) (NP (NP (NN BMI)) (NP (NP (QP (JJR >) (CD 35)) (NN kg/m2)) (, ,) (NP (JJ aged) (QP (JJR <) (CD 60)) (NNS years)) (, ,) (CC and) (NP (NP (NNS women)) (PP (IN with) (NP (JJ prior) (NN GDM)))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (S (NP (NP (NP (NN •) (JJ Continuous) (NN glucose) (NN monitoring)) (PRN (-LRB- -LRB-) (NP (NN CGM)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (JJ intensive) (NN insulin) (NNS regimens)))))) (VP (MD can) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN tool)) (PP (TO to) (NP (NP (JJR lower) (NN A1C)) (PP (IN in) (NP (NP (VBN selected) (NNS adults)) (PRN (-LRB- -LRB-) (NP (JJ aged) (JJR >) (JJ =) (CD 25) (NNS years)) (-RRB- -RRB-)))))) (PP (IN with) (NP (NN type) (CD 1) (NN diabetes)))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (NP (NP (NN •)) (SBAR (IN Although) (S (NP (NP (DT the) (NN evidence)) (PP (IN for) (NP (NN A1C) (NN lowering)))) (VP (VBZ is) (S (ADJP (RBR less) (JJ strong)) (PP (IN in) (NP (NP (NNS children)) (, ,) (NP (NNS teens)) (, ,) (CC and) (NP (JJR younger) (NNS adults)))) (, ,) (NP (NNP CGM)) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (PP (IN in) (NP (DT these) (NNS groups)))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))
(ROOT (PRN (S (NP (NN A1C) (CD •)) (VP (VBP Perform) (NP (DT the) (NN A1C) (NN test)) (NP (NP (QP (IN at) (JJS least) (CD two)) (NNS times)) (NP (DT a) (NN year))) (PP (IN in) (NP (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (NP (NP (NN meeting) (NN treatment) (NNS goals)) (-LRB- -LRB-) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (JJ stable) (JJ glycemic) (NN control))))))))))) (-RRB- -RRB-) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (ADVP (RB •)) (VP (VB Perform) (NP (DT the) (NN A1C) (NN test)) (ADVP (RB quarterly)) (PP (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP$ whose) (NN therapy)) (S (VP (VBZ has) (VP (VBN changed))))))) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBP are) (RB not) (VP (VBG meeting) (NP (JJ glycemic) (NNS goals)))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (NP (NP (NN •) (NN Use)) (PP (IN of) (NP (NP (JJ point-of-care) (NN testing)) (PP (IN for) (NP (NN A1C)))))) (VP (VBZ provides) (NP (NP (DT the) (NN opportunity)) (PP (IN for) (NP (ADJP (JJR more) (JJ timely)) (NN treatment) (NNS changes))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT a) (JJ reasonable) (NN A1C) (NN goal)) (PP (IN for) (NP (JJ many) (JJ nonpregnant) (NNS adults)))) (VP (VBZ is) (NP (QP (JJR <) (CD 7)) (NN %))) (. .)))
(ROOT (S (S (NP (NP (JJ Glycemic) (NNS goals)) (PP (IN in) (NP (NNS adults)))) (VP (VBP •) (S (VP (VBG Lowering) (NP (NN A1C)) (PP (PP (TO to) (PP (IN below))) (CC or) (NP (QP (IN around) (CD 7)) (NN %)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB reduce) (NP (NP (JJ microvascular) (NNS complications)) (PP (IN of) (NP (NN diabetes))))))))))) (, ,) (CC and) (FRAG (SBAR (IN if) (S (VP (VBN implemented) (ADVP (RB soon)) (SBAR (IN after) (S (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ long-term) (NN reduction)) (PP (IN in) (NP (JJ macrovascular) (NN disease))))))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (S (NP (NN •) (NNS Providers)) (VP (MD might) (ADVP (RB reasonably)) (VP (VB suggest) (NP (NP (NP (ADJP (RBR more) (JJ stringent)) (NN A1C) (NNS goals)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (QP (JJR <) (CD 6.5)) (NN %))) (-RRB- -RRB-))) (PP (IN for) (NP (VBN selected) (JJ individual) (NNS patients))))))) (, ,) (SBAR (IN if) (S (NP (DT this)) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN without) (NP (NP (JJ significant) (NN hypoglycemia)) (CC or) (NP (NP (JJ other) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NN treatment))))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))
(ROOT (S (NP (NP (NN •) (RBR Less) (JJ stringent) (NN A1C) (NNS goals)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (QP (JJR <) (CD 8)) (NN %))) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (ADJP (JJ appropriate) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ severe) (NN hypoglycemia)))))))))) (, ,) (NP (NP (NP (JJ limited) (NN life) (NN expectancy)) (, ,) (VP (VBD advanced) (NP (ADJP (ADJP (JJ microvascular)) (CC or) (ADJP (JJ macrovascular))) (NNS complications))) (, ,) (NP (JJ extensive) (NN comorbid) (NNS conditions)) (, ,) (CC and) (NP (NP (NP (DT those)) (PP (IN with) (NP (JJ long-standing) (NN diabetes)))) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (DT the) (JJ general) (NN goal)) (VP (VBZ is) (NP (ADJP (ADJP (JJ difficult) (SBAR (S (VP (TO to) (VP (VB attain) (PP (IN despite) (NP (NP (NN diabetes) (NN self-management) (NN education)) (PRN (-LRB- -LRB-) (NP (NN DSME)) (-RRB- -RRB-))))))))) (, ,) (ADJP (JJ appropriate))) (NN glucose) (NN monitoring))))))) (, ,) (CC and) (NP (NP (NP (JJ effective) (NNS doses)) (PP (IN of) (NP (JJ multiple) (NN glucose-lowering) (NNS agents)))) (PP (VBG including) (NP (NN insulin))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (NP (NN •)) (PP (IN In) (NP (NP (ADJP (RB newly) (VBN diagnosed)) (NN type) (CD 2) (JJ diabetic) (NNS patients)) (PP (IN with) (NP (NP (ADJP (ADJP (RB markedly) (JJ symptomatic)) (CC and/or) (ADJP (JJ elevated))) (NN blood) (NN glucose) (NNS levels)) (CC or) (NP (NN A1C)))))) (, ,) (VP (VBP consider) (NP (NP (NN insulin) (NN therapy)) (, ,) (PP (PP (PP (IN with)) (CC or) (PP (IN without))) (NP (NP (JJ additional) (NNS agents)) (, ,) (PP (IN from) (NP (DT the) (NN outset))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (NP (NP (NN •)) (SBAR (IN If) (S (NP (NP (JJ noninsulin) (NN monotherapy)) (PP (IN at) (NP (JJ maximal) (VBN tolerated) (NN dose)))) (VP (VBZ does) (RB not) (VP (VB achieve) (CC or) (VB maintain) (NP (DT the) (NN A1C) (NN target)) (PP (IN over) (NP (NP (CD 3)) (: --) (NP (CD 6) (NNS months)) (, ,))) (VP (VB add) (NP (NP (DT a) (JJ second) (JJ oral) (NN agent)) (, ,) (NP (NP (NP (DT a) (JJ glucagon-like) (NN peptide-1)) (PRN (-LRB- -LRB-) (NP (NN GLP-1)) (-RRB- -RRB-))) (NN receptor) (NN agonist)) (, ,) (CC or) (NP (NN insulin)))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (S (NP (NN Preconception) (NN care) (NN c) (NN A1C) (NNS levels)) (VP (MD should) (VP (VB be) (ADJP (ADJP (RB as) (JJ close) (PP (TO to) (NP (JJ normal)))) (PP (IN as) (ADJP (JJ possible)))))) (PRN (-LRB- -LRB-) (NP (QP (JJR <) (CD 7)) (NN %)) (-RRB- -RRB-)) (PP (IN in) (NP (DT an) (JJ individual) (NN patient))) (SBAR (IN before) (S (NP (NN conception)) (VP (VBZ is) (VP (VBN attempted))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (NP (NP (NP (NN Use)) (PP (IN of) (NP (NN A1C))) (SBAR (IN as) (S (NP (NP (DT a) (JJ screening) (NN test)) (PP (IN for) (NP (NNP CFRD)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (NP (NN •)) (VP (VP (VB Consider) (S (VP (VBG obtaining) (NP (NP (DT an) (NN A1C)) (PP (IN on) (NP (NP (NNS patients)) (PP (IN with) (NP (NN diabetes))))))))) (VBD admitted) (PP (TO to) (NP (DT the) (NN hospital))) (SBAR (IN if) (S (NP (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (NN testing)) (PP (IN in) (NP (DT the) (JJ previous) (CD 2)))))) (: --) (CD 3) (NNS months)) (VP (VBZ is) (RB not) (ADJP (JJ available)))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (NP (NN •)) (VP (VB Consider) (S (VP (VBG obtaining) (NP (NP (DT an) (NN A1C)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN risk) (NNS factors))))) (PP (IN for) (NP (NP (JJ undiagnosed) (NN diabetes)) (SBAR (WHNP (WP who)) (S (VP (VBP exhibit) (NP (NN hyperglycemia)) (PP (IN in) (NP (DT the) (NN hospital)))))))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (SBAR (IN Although) (S (NP (NP (NP (NN point-of-care)) (PRN (-LRB- -LRB-) (NP (NN POC)) (-RRB- -RRB-))) (NN A1C) (NNS assays)) (VP (MD may) (VP (VB be) (SBAR (S (NP (NN NGSP)) (VP (VBD certified)))))))) (, ,) (S (NP (NN proficiency) (NN testing)) (VP (VBZ is) (RB not) (VP (VBN mandated) (PP (IN for) (S (VP (VBG performing) (NP (DT the) (NN test)))))))) (, ,) (RB so) (S (NP (NP (NN use)) (PP (IN of) (NP (DT these) (NNS assays))) (PP (IN for) (NP (JJ diagnostic) (NNS purposes)))) (VP (MD could) (VP (VB be) (ADJP (JJ problematic))))) (. .)))
(ROOT (FRAG (PP (IN In) (NP (CD 2009))) (, ,) (NP (NP (DT an) (NNP International) (NNP Expert) (NNP Committee)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NP (NNS representatives)) (PP (IN of) (NP (NP (DT the) (NN ADA)) (, ,) (NP (NP (DT the) (NNP International) (NNP Diabetes) (NNP Table) (CD 1) (NN ADA) (NN evidence)) (VP (VBG grading) (NP (NN system)) (PP (IN for) (NP (NP (JJ clinical) (NN practice) (NNS recommendations) (NN Level)) (PP (IN of) (NP (NP (NN evidence) (NN Description) (NN A) (JJ Clear) (NN evidence)) (PP (IN from) (NP (NP (JJ well-conducted) (, ,) (JJ generalizable) (NNS RCTs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (ADVP (RB adequately)) (VBN powered) (, ,) (NP (NP (VBG including) (: :) (NP (NP (CD •) (NN Evidence)) (PP (IN from) (NP (NP (DT a) (JJ well-conducted) (JJ multicenter) (NN trial) (CD •) (NN Evidence)) (PP (IN from) (NP (NP (NP (DT a) (NN meta-analysis)) (SBAR (WHNP (WDT that)) (S (VP (VBD incorporated) (NP (NP (NN quality) (NNS ratings)) (PP (IN in) (NP (DT the) (NN analysis) (NN •) (NN ompelling) (JJ nonexperimental) (NN evidence)))))))) (, ,) (FW i.e.)))))) (, ,) (`` ``) (NP (DT all)) (CC or) (NP (NN none)) ('' '') (NP (NN rule))) (VP (VBN developed) (PP (IN by) (NP (DT the) (NNP Centre))) (PP (IN for) (NP (NNP Evidence-Based) (NNP Medicine))) (PP (IN at) (NP (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Oxford) (JJ Supportive) (NN evidence))) (PP (IN from) (NP (JJ well-conducted) (NNS RCTs)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB adequately)) (VP (VBN powered) (, ,) (S (VBG including) (: :) (S (S (NP (NP (CD •) (NN Evidence)) (PP (IN from) (NP (NP (DT a) (JJ well-conducted) (NN trial)) (PP (IN at) (NP (QP (CD one) (CC or) (JJR more)) (NNS institutions)))))) (VP (VBP •) (NP (NN Evidence)) (PP (IN from) (NP (NP (DT a) (NN meta-analysis)) (SBAR (WHNP (WDT that)) (S (VP (VBD incorporated) (NP (NP (NN quality) (NNS ratings)) (PP (IN in) (NP (NP (DT the) (NN analysis) (NN B) (JJ Supportive) (NN evidence)) (PP (IN from) (NP (JJ well-conducted) (NN cohort) (NNS studies))))))))))))) (VP (VBP •) (NP (NN Evidence)) (PP (IN from) (NP (NP (NP (DT a) (JJ well-conducted) (JJ prospective) (NN cohort) (NN study)) (CC or) (NP (NN registry) (CD •) (NN Evidence))) (PP (IN from) (NP (NP (NP (DT a) (JJ well-conducted) (NN meta-analysis)) (PP (IN of) (NP (NN cohort) (NNS studies)))) (NP (NP (JJ Supportive) (NN evidence)) (PP (IN from) (NP (NP (DT a) (JJ well-conducted) (JJ case-control) (NN study)) (NP (NP (ADJP (RB •) (JJ Supportive)) (NN evidence)) (PP (IN from) (NP (ADJP (ADJP (RB poorly) (VBN controlled)) (CC or) (ADJP (JJ uncontrolled))) (NNS studies))))))))))) (VP (VBP •) (NP (NP (NN Evidence)) (PP (IN from) (S (VP (VBN randomized) (NP (NP (JJ clinical) (NNS trials)) (PP (IN with) (NP (NP (QP (CD one) (CC or) (JJR more)) (ADJP (JJ major) (CC or) (QP (CD three) (CC or) (JJR more)) (JJ minor)) (JJ methodological) (NNS flaws)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB invalidate) (S (NP (DT the) (NNS results)) (VP (VBP •) (NP (NP (NN Evidence)) (PP (IN from) (NP (NP (NP (JJ observational) (NNS studies)) (PP (IN with) (NP (NP (JJ high) (NN potential)) (PP (IN for) (NP (NP (NN bias)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (NP (NN case) (NN series)) (PP (IN with) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ historical) (NNS controls))))))) (-RRB- -RRB-))))))) (NP (NP (CD •) (NN Evidence)) (PP (IN from) (S (NP (NP (NN case) (NN series)) (CC or) (NP (NN case) (NNS reports))) (VP (VBG Conflicting) (NP (NP (NN evidence)) (PP (IN with) (NP (NP (DT the) (NN weight)) (PP (IN of) (NP (NP (NN evidence)) (VP (VBG supporting) (NP (NP (DT the) (NN recommendation) (NN E) (NN Expert) (NN consensus)) (CC or) (NP (NP (JJ clinical) (NN experience) (NNP Federation)) (PRN (-LRB- -LRB-) (NP (NNP IDF)) (-RRB- -RRB-))))))))))))))))))))))))))))))))) (, ,) (CC and) (S (S (S (NP (DT the) (NNP European) (NNP Association)) (PP (IN for) (NP (NP (DT the) (NN Study)) (PP (IN of) (NP (NNP Diabetes)))))) (PRN (-LRB- -LRB-) (NP (NNP EASD)) (-RRB- -RRB-))) (VP (VBD recommended) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN A1C) (NN test))) (S (S (VP (TO to) (VP (VB diagnose) (NP (NN diabetes)) (, ,) (PP (IN with) (NP (NP (DT a) (NN threshold)) (PP (IN of) (NP (NP (JJR >) (JJ =) (CD 6.5) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-)))))))) (, ,)) (CC and) (S (NP (DT the) (NN ADA)) (VP (VBN adopted) (NP (DT this) (NN criterion)) (PP (IN in) (NP (CD 2010) (-LRB- -LRB-) (CD 5) (-RRB- -RRB-))))))))))))))))))))))))))))))))))))) (. .)))
(ROOT (S (NP (JJ Epidemiological) (NNS datasets)) (VP (VBP show) (NP (NP (DT a) (JJ similar) (NN relationship)) (PP (IN for) (NP (NP (NN A1C)) (PP (TO to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN retinopathy)))))))) (SBAR (IN as) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN for) (NP (DT the) (JJ corresponding) (NNP FPG) (CC and) (JJ 2-h) (NN PG) (NNS thresholds))))))))) (. .)))
(ROOT (S (NP (DT The) (NN A1C)) (VP (VBZ has) (NP (NP (NP (JJ several) (NNS advantages)) (PP (TO to) (NP (NP (DT the) (NNP FPG)) (CC and) (NP (NNP OGTT)) (, ,) (PP (VBG including) (NP (NP (JJR greater) (NN convenience)) (PRN (-LRB- -LRB-) (SBAR (IN since) (S (NP (NN fasting)) (VP (VBZ is) (RB not) (VP (VBN required))))) (-RRB- -RRB-))))))) (, ,) (NP (NP (NN evidence)) (SBAR (S (VP (TO to) (VP (VB suggest) (NP (JJR greater) (JJ preanalytical) (NN stability))))))) (, ,) (CC and) (NP (NP (ADJP (RBR less) (JJ day-to-day)) (NNS perturbations)) (PP (IN during) (NP (NP (NNS periods)) (PP (IN of) (NP (NP (NN stress)) (CC and) (NP (NN illness))))))))) (. .)))
(ROOT (FRAG (S (NP (DT These) (NNS advantages)) (VP (MD must) (VP (VB be) (VP (VBN balanced) (PP (IN by) (NP (JJR greater) (NN cost))))))) (, ,) (NP (NP (NP (DT the) (JJ limited) (NN availability)) (PP (IN of) (NP (NP (NN A1C) (NN testing)) (PP (IN in) (NP (NP (JJ certain) (NNS regions)) (PP (IN of) (NP (DT the) (VBG developing) (NN world)))))))) (, ,) (CC and) (NP (NP (DT the) (JJ incomplete) (NN correlation)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (NP (JJ average) (NN glucose)) (PP (IN in) (NP (JJ certain) (NNS individuals)))))))) (. .)))
(ROOT (S (NP (DT A) (JJ recent) (JJ epidemiological) (NN study)) (VP (VBD found) (SBAR (SBAR (IN that) (, ,) (S (S (SBAR (WHADVP (WRB when)) (S (VP (VBN matched) (PP (IN for) (NP (NP (NNP FPG)) (, ,) (NP (NP (NNP African) (NNPS Americans)) (-LRB- -LRB-) (PP (PP (PP (IN with)) (CC and) (PP (IN without))) (NP (NN diabetes))) (-RRB- -RRB-))))))) (ADVP (RB indeed)) (VP (VBD had) (NP (NP (JJR higher) (NN A1C)) (PP (IN than) (NP (NNS whites)))))) (, ,) (CC but) (S (ADVP (RB also)) (VP (VBD had) (NP (NP (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP (NN fructosamine)))) (CC and) (NP (VBN glycated) (NN albumin))) (CC and) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (CD 1,5) (NN anhydroglucitol))))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (PRP$ their) (JJ glycemic) (NN burden)) (PRN (-LRB- -LRB-) (ADVP (RB particularly) (RB postprandially)) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (ADJP (JJR higher) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (S (NP (NP (JJ Epidemiological) (NNS studies)) (VP (VBG forming) (NP (NP (DT the) (NN framework)) (PP (IN for) (S (VP (VBG recommending) (NP (NP (NN use)) (PP (IN of) (NP (DT the) (NN A1C)))) (S (VP (TO to) (VP (VB diagnose) (NP (NNS diabetes))))))))))) (VP (VBP have) (DT all) (VP (VBN been) (PP (IN in) (NP (JJ adult) (NNS populations))))) (. .)))
(ROOT (S (NP (NN A1C)) (ADVP (RB inaccurately)) (VP (VBZ reflects) (NP (NP (NN glycemia)) (PP (IN with) (NP (JJ certain) (NNS anemias) (CC and) (NNS hemoglobinopathies))))) (. .)))
(ROOT (FRAG (PP (IN For) (NP (NP (NNS patients)) (PP (IN with) (NP (DT an) (JJ abnormal) (NN hemoglobin))))) (PP (CC but) (NP (NP (JJ normal) (JJ red) (NN cell) (NN turnover)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ sickle) (NN cell) (NN trait)) (, ,) (NP (NP (DT an) (NN A1C) (NN assay)) (PP (IN without) (NP (NP (NN interference)) (PP (IN from) (NP (JJ abnormal) (NNS hemoglobins)))))) (VP (MD should) (VP (VB be) (VP (VBN used) (S (-LRB- -LRB-) (NP (DT an) (VBN updated) (NN list)) (VP (VBZ is) (ADJP (JJ available) (PP (IN at) (NP (NN www))))))))))))) (. .)))
(ROOT (FRAG (LST (NP (NN ngsp.org/interf.asp)) (-RRB- -RRB-)) (. .)))
(ROOT (S (SBAR (RB Just) (IN as) (S (NP (EX there)) (VP (VBZ is) (NP (NP (ADJP (QP (JJR less) (IN than) (CD 100)) (NN %)) (NN concordance)) (PP (IN between) (NP (DT the) (NNP FPG) (CC and) (JJ 2-h) (NN PG) (NNS tests))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (JJ perfect) (NN concordance)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (CC either) (NP (JJ glucose-based) (NN test))))))) (. .)))
(ROOT (NP (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (DT the) (NNP National) (NNP Health)) (CC and) (NP (NP (NNP Nutrition) (NNP Examination) (NN Survey)) (PRN (-LRB- -LRB-) (NP (NN NHANES)) (-RRB- -RRB-)))))) (NP (NNS data) (S (VP (VBP indicate) (SBAR (IN that) (, ,) (S (S (S (VP (VBG assuming) (NP (NP (JJ universal) (NN screening)) (PP (IN of) (NP (DT the) (JJ undiagnosed)))))) (, ,) (NP (NP (DT the) (NN A1C) (NN cut) (NN point)) (PP (IN of) (NP (JJR >) (JJ =) (CD 6.5) (NN %)))) (VP (VBZ identifies) (NP (NP (NP (ADJP (JJ one-third) (JJR fewer)) (NNS cases)) (PP (IN of) (NP (JJ undiagnosed) (NN diabetes)))) (PP (IN than) (NP (NP (DT a) (NN fasting) (NN glucose) (NN cut) (NN point)) (PP (IN of) (NP (NP (NP (JJR >) (JJ =) (CD 126) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 7.0) (NN mmol/L)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (JJ numerous) (NNS studies)) (VP (VBP have) (VP (VBN confirmed) (SBAR (IN that) (S (PP (IN at) (NP (DT these) (NN cut))) (VP (VBZ points) (SBAR (S (NP (DT the) (JJ 2-h) (NN OGTT) (NN value)) (VP (VBZ diagnoses) (NP (ADJP (RBR more) (VBN screened)) (NNS people)) (PP (IN with) (NP (NP (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))))))))))))))))) (. .)))
(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (JJR lower) (NN sensitivity)) (PP (IN of) (NP (NN A1C))) (PP (IN at) (NP (DT the) (VBN designated) (NN cut) (NN point)))) (VP (MD may) (ADVP (RB well)) (VP (VB be) (VP (VBN offset) (PP (IN by) (NP (NP (NP (DT the) (NN test) (POS 's)) (JJR greater) (NN practicality)) (, ,) (CC and) (NP (NP (JJR wider) (NN application)) (PP (IN of) (NP (NP (DT a) (ADJP (RBR more) (JJ convenient)) (NN test)) (PRN (-LRB- -LRB-) (NP (NN A1C)) (-RRB- -RRB-)))))))))) (VP (MD may) (ADVP (RB actually)) (VP (VB increase) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS diagnoses)) (VP (VBN made))))))) (. .)))
(ROOT (S (PP (IN For) (NP (NN example))) (, ,) (SBAR (IN if) (S (S (NP (DT the) (NN A1C)) (VP (VBZ is) (NP (CD 7.0) (NN %)))) (CC and) (S (NP (DT a) (NN repeat) (NN result)) (VP (VBZ is) (NP (CD 6.8) (NN %)))))) (, ,) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ is) (VP (VBN confirmed))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN if) (S (NP (NP (CD two) (JJ different) (NNS tests)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (NP (NN A1C)) (CC and) (NP (NN FPG)))) (-RRB- -RRB-))) (VP (VBP are) (PP (DT both) (IN above) (NP (DT the) (JJ diagnostic) (NNS thresholds)))))) (, ,) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN confirmed))) (. .)))
(ROOT (SINV (S (NP (DT That)) (VP (VBZ is))) (, ,) (SBAR (IN if) (S (S (NP (DT a) (NN patient)) (VP (VBZ meets) (NP (NP (DT the) (NN diabetes) (NN criterion)) (PP (IN of) (NP (NP (DT the) (NN A1C)) (PRN (-LRB- -LRB-) (S (NP (CD two) (NNS results)) (NP (JJR >) (JJ =) (CD 6.5) (NN %))) (-RRB- -RRB-))))))) (CC but) (NP (NP (NP (RB not) (DT the) (NNP FPG)) (PRN (-LRB- -LRB-) (NP (NP (QP (JJR <) (CD 126)) (NN mg)) (: /) (NP (NP (NN dL)) (CC or) (NP (CD 7.0) (NN mmol/L)))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN vice) (RB versa) (, ,) (SBAR (IN that) (S (NP (NN person)) (VP (MD should) (VP (VB be) (VP (VBN considered) (S (VP (TO to) (VP (VB have) (NP (NN diabetes)))))))))))))) (. .)))
(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (RBS least) (JJ likely) (PP (IN for) (NP (NN A1C)))) (, ,) (ADJP (RB somewhat) (ADJP (RBR more) (JJ likely) (PP (IN for) (NP (NNP FPG)))) (, ,) (CC and) (ADJP (RBS most) (JJ likely))) (PP (IN for) (NP (DT the) (JJ 2-h) (NN PG)))) (. .)))
(ROOT (S (SBAR (IN As) (S (VP (VBZ is) (NP (NP (DT the) (NN case)) (PP (IN with) (NP (DT the) (NN glucose) (NNS measures))))))) (, ,) (NP (NP (JJ several) (JJ prospective) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBD used) (NP (NN A1C)) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN progression)) (PP (TO to) (NP (NN diabetes))))))))))) (VP (VBD demonstrated) (NP (NP (DT a) (JJ strong) (, ,) (JJ continuous) (NN association)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (JJ subsequent) (NN diabetes)))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (NP (DT a) (JJ systematic) (NN review)) (PP (IN of) (NP (CD 44,203) (NNS individuals)))) (PP (IN from) (NP (NP (CD 16) (NN cohort)) (NNS studies))) (PP (IN with) (S (NP (DT a) (JJ follow-up) (NN interval)) (VP (VBG averaging) (NP (NP (CD 5.6) (NNS years)) (PRN (-LRB- -LRB-) (NP (NP (NN range) (CD 2.8)) (: --) (NP (CD 12) (NNS years))) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT those)) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN between) (NP (QP (CD 5.5) (CC and) (CD 6.0)) (NN %)))))) (VP (VBD had) (NP (NP (DT a) (ADJP (RB substantially) (VBN increased)) (NN risk)) (PP (IN of) (NP (NN diabetes))) (PP (IN with) (NP (NP (JJ 5-year) (NNS incidences)) (VP (VBG ranging) (PP (PP (IN from) (NP (CD 9))) (PP (TO to) (NP (CD 25) (NN %))))))))) (. .)))
(ROOT (S (NP (NP (DT An) (NN A1C) (NN range)) (PP (IN of) (NP (CD 6.0)))) (: --) (NP (ADJP (CD 6.5) (NN %))) (VP (VBD had) (NP (NP (DT a) (JJ 5-year) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NN diabetes)) (PP (IN between) (NP (NP (NP (NP (QP (CD 25) (TO to) (CD 50) (NN %) (CC and) (JJ relative)) (NN risk)) (PRN (-LRB- -LRB-) (NP (NN RR)) (-RRB- -RRB-))) (QP (CD 20) (NNS times))) (ADJP (JJR higher)))) (PP (VBN compared) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (NP (CD 5.0) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (NP (DT a) (JJ communitybased) (NN study)) (PP (IN of) (NP (ADJP (JJ black) (CC and) (JJ white)) (NNS adults)))) (PP (IN without) (NP (NN diabetes))))) (, ,) (NP (NN baseline) (NN A1C)) (VP (VBD was) (NP (NP (NP (DT a) (JJR stronger) (NN predictor)) (PP (IN of) (NP (NP (JJ subsequent) (NN diabetes)) (CC and) (NP (JJ cardiovascular) (NNS events))))) (SBAR (IN than) (S (VP (VBD was) (VP (VBG fasting) (NP (NP (NN glucose)) (PRN (-LRB- -LRB-) (NP (CD 16)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (NP (JJ Other) (NNS analyses)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7) (NN %)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN diabetes) (NN risk)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN in) (NP (NP (DT the) (NN highrisk) (NNS participants)) (PP (IN in) (NP (NP (DT the) (NNP Diabetes) (NNP Prevention) (NNP Program)) (PRN (-LRB- -LRB-) (NP (NNP DPP)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD 17)) (-RRB- -RRB-)))))))))))))))) (. .)))
(ROOT (NP (NP (NP (NNP Table) (CD 2) (NNP Criteria)) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NN diabetes) (NN A1C)) (JJR >) (JJ =) (CD 6.5) (NN %)))))) (. .)))
(ROOT (S (ADVP (RB Hence)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB consider) (NP (NP (NP (DT an) (NN A1C) (NN range)) (PP (IN of) (NP (CD 5.7)))) (PRN (: --) (NP (NP (CD 6.4) (NN %)) (PP (IN as) (S (VP (VBG identifying) (NP (NNS individuals)) (PP (IN with) (NP (NNS prediabetes)))))))))))))) (. .)))
(ROOT (S (SBAR (IN As) (S (VP (VBZ is) (NP (NP (DT the) (NN case)) (PP (IN for) (NP (NP (NNS individuals)) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NNP IFG) (CC and) (NNP IGT)))))))))))) (, ,) (NP (NP (NNS individuals)) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7)))))) (: --) (NP (CD 6.4) (NN %)) (VP (VP (MD should) (VP (VB be) (VP (VBN informed) (PP (PP (IN of) (NP (NP (PRP$ their) (VBN increased) (NN risk)) (PP (IN for) (NP (NN diabetes))))) (CONJP (RB as) (RB well) (IN as)) (NP (NN CVD)))))) (CC and) (VP (VBD counseled) (PP (IN about) (NP (JJ effective) (NNS strategies) (S (VP (TO to) (VP (VB lower) (NP (PRP$ their) (NNS risks)))))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NN Section) (CD IV)))) (-RRB- -RRB-))) (. .)))
(ROOT (S (PP (IN As) (PP (IN with) (NP (NN glucose) (NNS measurements)))) (, ,) (NP (NP (DT the) (NN continuum)) (PP (IN of) (NP (NN risk)))) (VP (VBZ is) (ADJP (JJ curvilinear)) (, ,) (SBAR (IN so) (IN that) (S (PP (IN as) (NP (NN A1C) (NNS rises))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ rises) (ADVP (RB disproportionately)) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))))) (. .)))
(ROOT (S (ADVP (RB Accordingly)) (, ,) (NP (NNS interventions)) (VP (MD should) (VP (VB be) (ADJP (RBS most) (JJ intensive) (CC and) (JJ follow-up)) (ADJP (RB particularly) (JJ vigilant) (PP (IN for) (NP (NP (DT those)) (PP (IN with) (NP (NP (NNS A1Cs)) (ADVP (IN above) (NP (CD 6.0) (NN %))) (, ,) (SBAR (WHNP (WP who)) (S (VP (MD should) (VP (VB be) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (ADJP (RB very) (JJ high)) (NN risk)))))))))))))))))) (. .)))
(ROOT (NP (NN •) (S (S (VP (TO To) (VP (VB test) (PP (IN for) (NP (NP (NN diabetes)) (CC or) (NP (NNS prediabetes))))))) (, ,) (NP (NP (DT the) (NN A1C)) (, ,) (NP (NNP FPG)) (, ,) (CC or) (NP (JJ 75-g) (JJ 2-h) (NN OGTT))) (VP (VBP are) (ADJP (JJ appropriate)))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (NP (NP (NNP Table) (CD 3) (NNS Categories)) (PP (IN of) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (NP (NP (NN diabetes)) (PRN (-LRB- -LRB-) (NP (NNS prediabetes)) (-RRB- -RRB-)))))) (S (X (SYM *)) (VP (SYM FPG) (NP (NP (NP (CD 100) (NN mg/dL) (PRN (-LRB- -LRB-) (NP (CD 5.6) (NN mmol/L)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NP (CD 125) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 6.9) (NN mmol/L)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN IFG)) (-RRB- -RRB-))))) (SBAR (S (NP (NP (NN OR) (JJ 2-h) (NN plasma) (NN glucose)) (PP (IN in) (NP (NP (DT the) (JJ 75-g) (NN OGTT) (CD 140) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 7.8) (NN mmol/L)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NP (NP (CD 199) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 11.0) (NN mmol/L)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP IGT)) (-RRB- -RRB-))) (VP (NN OR) (NP (NP (NN A1C) (CD 5.7)) (: --) (NP (NP (ADJP (CD 6.4) (NN %)) (NN *)) (PP (IN For) (NP (DT all) (CD three) (NNS tests)))) (, ,) (NP (NN risk))))))) (VP (VBZ is) (ADJP (JJ continuous)) (, ,) (S (VP (VP (VBG extending) (PP (IN below) (NP (NP (DT the) (JJR lower) (NN limit)) (PP (IN of) (NP (DT the) (NN range)))))) (CC and) (VP (VBG becoming) (ADJP (RB disproportionately) (JJR greater) (PP (IN at) (NP (NP (JJR higher) (NNS ends)) (PP (IN of) (NP (DT the) (NN range))))))))))))))) (. .)))
(ROOT (S (NP (NP (DT The) (NN A1C)) (, ,) (NP (NNP FPG)) (, ,) (CC or) (NP (DT the) (JJ 2-h) (NN OGTT))) (VP (VBP are) (ADJP (JJ appropriate) (PP (IN for) (NP (NN testing))))) (. .)))
(ROOT (NP (NP (DT The) (NN efficacy)) (PP (IN of) (NP (NP (NNS interventions)) (SBAR (IN for) (S (NP (JJ primary) (NN prevention)) (IN of) (NP (NN type) (CD 2) (NN diabetes)) (-LRB- -LRB-) (S (NP (CD 23) (PRN (: --) (NP (CD 29)) (-RRB- -RRB-))) (VP (VBZ has) (ADVP (RB primarily)) (VP (VBN been) (VP (VBN demonstrated) (PP (IN among) (NP (NP (NNS individuals)) (PP (IN with) (NP (NNP IGT))))) (, ,) (PP (RB not) (IN for) (NP (NP (NNS individuals)) (SBAR (IN with) (S (VP (VBN isolated) (NP (NP (NNP IFG)) (CC or) (PP (IN for) (NP (NP (NNS individuals)) (PP (IN with) (NP (JJ specific) (NN A1C) (NNS levels))))))))))))))))))) (. .)))
(ROOT (LST (LS 1) (. .)))
(ROOT (FRAG (S (VP (VBG Testing) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT all) (NNS adults)) (SBAR (WHNP (WP who)) (S (VP (VP (VBP are) (ADJP (JJ overweight) (PRN (-LRB- -LRB-) (NP (NN BMI) (JJR >) (JJ =) (CD 25) (NN kg/m2) (NN *)) (-RRB- -RRB-)))) (CC and) (VP (VBP have) (NP (JJ additional) (NN risk) (NNS factors))))))))))))) (: :) (NP (NP (CD •) (JJ physical) (NN inactivity) (CD •) (JJ first-degree) (JJ relative)) (PP (IN with) (S (NP (NN diabetes) (CD •) (JJ high-risk) (NN race/ethnicity)) (-LRB- -LRB-) (NP (NP (ADVP (FW e.g.)) (PRN (, ,) (NP (NP (JJ African) (NNP American)) (, ,) (NP (NP (NNP Latino)) (, ,) (NP (JJ Native) (NNP American))) (, ,)) (NP (NP (NNP Asian) (NNP American)) (, ,) (NP (NNP Pacific) (NNP Islander)))) (-RRB- -RRB-) (CD •) (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD delivered) (NP (DT a) (NN baby)) (S (VP (VBG weighing) (NP (CD .9) (NN lb))))) (CC or) (VP (VBD were) (VP (VBN diagnosed) (PP (IN with) (NP (NP (NP (NN GDM) (CD •) (NN hypertension)) (PRN (-LRB- -LRB-) (NP (NP (JJR >) (JJ =) (CD 140/90) (NN mmHg)) (CC or) (PP (IN on) (NP (NP (NN therapy)) (PP (IN for) (NP (NN hypertension)))))) (-RRB- -RRB-))) (NP (NP (CD •) (NN HDL) (NN cholesterol) (NN level)) (NP (NP (NP (NP (JJR <) (CD 35) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 0.90) (NN mmol/L)) (-RRB- -RRB-))) (CC and/or) (NP (NP (DT a) (NN triglyceride) (NN level) (CD .250) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 2.82) (NN mmol/L)) (-RRB- -RRB-)))) (NP (NP (CD •) (NNS women)) (PP (IN with) (NP (NP (NP (JJ polycystic) (JJ ovary) (NN syndrome) (CD •) (NN A1C)) (JJR >) (JJ =) (CD 5.7) (NN %)) (, ,) (NP (NNP IGT)) (, ,) (CC or) (NP (NP (NNP IFG)) (PP (IN on) (NP (NP (JJ previous) (NN testing) (CD •) (JJ other) (JJ clinical) (NNS conditions)) (VP (VBN associated) (PP (IN with) (NP (NP (NN insulin) (NN resistance)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (ADVP (FW e.g.)) (PRN (, ,) (NP (NP (JJ severe) (NN obesity)) (, ,) (NP (NN acanthosis) (NNS nigricans))) (-RRB- -RRB-))) (NP (CD •) (NN history)) (PP (IN of) (NP (NN CVD))))))))))))))))))))))))))))))
(ROOT (S (PP (IN Because) (IN of) (NP (NP (PRP$ their) (NN prepartum) (NN treatment)) (PP (IN for) (NP (NN hyperglycemia))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (DT the) (NN A1C))) (PP (IN for) (NP (NP (NN diagnosis)) (PP (IN of) (NP (JJ persistent) (NN diabetes))) (PP (IN at) (NP (DT the) (JJ postpartum) (NN visit)))))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PRN (-LRB- -LRB-) (NP (CD 44)) (-RRB- -RRB-)))) (. .)))
(ROOT (NP (NP (NP (NP (NN PREVENTION/DELAY)) (PP (IN OF) (NP (NN TYPE) (CD 2) (NNP DIABETES) (NNPS Recommendations)))) (NP (NP (CD •) (NNS Patients)) (PP (IN with) (NP (NP (NP (NN IGT)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IFG)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7))))))) (: --) (NP (NP (CD 6.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (SBAR (S (VP (MD should) (VP (VB be) (VP (VBN referred) (PP (TO to) (NP (NP (DT an) (JJ effective) (JJ ongoing) (NN support) (NN program)) (VP (VP (VBG targeting) (NP (NP (NN weight) (NN loss)) (PP (IN of) (NP (NP (CD 7) (NN %)) (PP (IN of) (NP (NN body) (NN weight))))))) (CC and) (VP (VBG increasing) (NP (JJ physical) (NN activity)) (PP (TO to) (NP (NP (NP (QP (IN at) (JJS least) (CD 150)) (NN min/week)) (PP (IN of) (NP (JJ moderate) (NN activity)))) (PP (JJ such) (IN as) (S (VP (VBG walking)))))))))))))))) (. .)))
(ROOT (S (S (NP (NP (NN •) (NN Metformin) (NN therapy)) (PP (IN for) (NP (NP (NN prevention)) (PP (IN of) (NP (NN type) (CD 2) (NN diabetes)))))) (VP (MD may) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT those)) (PP (IN with) (NP (NP (NP (NN IGT)) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (NP (NP (NN IFG)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7)))))))))))) (: --) (NP (NP (NP (CD 6.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-))) (, ,) (PP (ADVP (RB especially)) (IN for) (NP (NP (DT those)) (PP (IN with) (NP (NP (NN BMI) (CD .35) (NN kg/m2)) (, ,) (NP (JJ aged) (CD ,60) (NNS years)) (, ,) (CC and) (NP (NP (NNS women)) (PP (IN with) (NP (JJ prior) (NN GDM))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (FRAG (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (JJ clinical) (NNS trials)) (CC and) (NP (NP (DT the) (JJ known) (NNS risks)) (PP (IN of) (NP (NP (NN progression)) (PP (IN of) (NP (NNS prediabetes)))))))) (PP (TO to) (NP (NNS diabetes)))))) (, ,) (NP (NP (NP (NNS persons)) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7)))))) (PRN (: --) (S (NP (NP (CD 6.4) (NN %)) (, ,) (NP (NNP IGT)) (, ,) (CC or) (NP (NNP IFG))) (VP (MD should) (VP (VB be) (VP (VBN counseled) (PP (IN on) (NP (NP (NN lifestyle) (NNS changes)) (PP (IN with) (NP (NP (NNS goals)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NP (NP (DT the) (NN DPP) (-LRB- -LRB-) (ADJP (CD 7) (NN %)) (NN weight) (NN loss)) (CC and) (NP (JJ moderate) (JJ physical) (NN activity))) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 150)) (NN min/week)))))))))))))))) (-RRB- -RRB-))) (. .)))
(ROOT (NP (NP (NNP Table) (CD 7) (NNP Components)) (PP (IN of) (NP (NP (DT the) (JJ comprehensive) (NN diabetes) (NN evaluation) (JJ Medical) (NN history) (JJ •) (NN Age)) (CC and) (NP (NP (NNS characteristics)) (PP (IN of) (NP (NP (NN onset)) (PP (IN of) (NP (NP (NN diabetes)) (SBAR (-LRB- -LRB-) (S (S (NP (NP (ADVP (FW e.g.)) (PRN (, ,) (NP (NP (NN DKA)) (, ,) (NP (JJ asymptomatic) (NN laboratory) (NN finding))) (-RRB- -RRB-)) (CD •) (NNP Eating) (NNS patterns)) (, ,) (NP (NP (JJ physical) (NN activity) (NNS habits)) (, ,) (NP (JJ nutritional) (NN status)) (, ,) (CC and) (NP (NN weight) (NN history))) (: ;) (NP (NP (NN growth) (CC and) (NN development)) (PP (IN in) (NP (NP (NNS children)) (CC and) (NP (NNS adolescents)))))) (VP (VBP •) (NP (NP (NP (NNP Diabetes) (NN education) (NN history) (CD •) (NN Review)) (PP (IN of) (NP (NP (JJ previous) (NN treatment) (NNS regimens)) (CC and) (NP (NP (NP (NN response)) (PP (TO to) (NP (NN therapy)))) (PRN (-LRB- -LRB-) (NP (NN A1C) (NNS records)) (-RRB- -RRB-)))))) (NP (NP (CD •) (JJ Current) (NN treatment)) (PP (IN of) (NP (NN diabetes))) (, ,) (PP (VBG including) (NP (NP (NNS medications)) (, ,) (NP (NN medication) (NN adherence)) (CC and) (NP (NP (NNS barriers)) (ADVP (RB thereto))))) (, ,) (NP (NN meal) (NN plan)) (, ,) (NP (JJ physical) (NN activity) (NNS patterns)) (, ,) (CC and) (NP (NP (NN readiness)) (PP (IN for) (NP (NP (NN behavior) (NN change) (CD •) (NNS Results)) (PP (IN of) (NP (NP (NN glucose) (NN monitoring)) (CC and) (NP (NP (NP (NN patient) (POS 's)) (NN use)) (PP (IN of) (NP (NNS data))))))))))))) (S (VP (VBP •) (NP (NP (NN DKA) (NN frequency)) (, ,) (NP (NN severity)) (, ,) (CC and) (VP (VB cause) (SBAR (S (NP (ADJP (RB •) (JJ Hypoglycemic)) (NNS episodes)) (VP (VBP •) (NP (NN Hypoglycemia) (NN awareness) (CD •)) (NP (DT Any) (JJ severe) (NN hypoglycemia))))))))) (: :) (NP (NP (NP (NN frequency)) (CC and) (NP (ADJP (VP (VB cause) (SBAR (S (NP (NP (CD •) (NN History)) (PP (IN of) (NP (JJ diabetes-related) (NNS complications)))) (VP (VBP •) (ADJP (JJ Microvascular))))))))) (: :) (NP (NP (NP (NP (NP (NP (NN retinopathy)) (, ,) (NP (NN nephropathy)) (, ,) (NP (NP (NN neuropathy)) (PRN (-LRB- -LRB-) (NP (NP (JJ sensory) (, ,) (PP (VBG including) (NP (NP (NN history)) (PP (IN of) (NP (NN foot) (NNS lesions)))))) (: ;) (NP (JJ autonomic)) (, ,) (PP (VBG including) (NP (NP (JJ sexual) (NN dysfunction)) (CC and) (NP (NN gastroparesis))))) (-RRB- -RRB-))) (NP (CD •) (NNP Macrovascular))) (: :) (NP (NN CHD)) (, ,) (NP (JJ cerebrovascular) (NN disease)) (, ,) (CC and) (NP (NN PAD) (CD •))) (ADJP (JJ Other))) (: :) (NP (JJ psychosocial) (NNS problems))) (UCP (X (SYM *)) (, ,) (NP (NP (NP (JJ dental) (NN disease) (NN *)) (NP (NP (JJ Physical) (NN examination) (CD •) (NN Height)) (, ,) (NP (NN weight)) (, ,) (NP (NN BMI) (CD •) (NN Blood) (NN pressure) (NN determination)) (, ,) (PP (VBG including) (NP (JJ orthostatic) (NNS measurements))))) (SBAR (WHADVP (WRB when)) (S (VBN indicated) (NP (CD •) (JJ Fundoscopic) (NN examination)) (X (SYM *)) (NP (NP (CD •) (NN Thyroid) (NN palpation) (CD •) (NN Skin) (NN examination)) (-LRB- -LRB-) (NP (NP (PP (IN for) (NP (NP (NN acanthosis) (NNS nigricans)) (CC and) (NP (NN insulin) (NN injection) (NNS sites)))) (-RRB- -RRB-) (CD •) (JJ Comprehensive) (NN foot) (NN examination) (CD •) (NNP Inspection) (CD •) (NN Palpation)) (PP (IN of) (NP (NP (NN dorsalis) (NN pedis)) (CC and) (NP (JJ posterior) (JJ tibial) (NNS pulses))))) (VP (VBP •) (SBAR (S (NP (NP (NN Presence/absence)) (PP (IN of) (NP (NP (NN patellar)) (CC and) (NP (NN Achilles) (NNS reflexes))))) (VP (VBP •) (NP (NP (NN Determination)) (PP (IN of) (NP (NP (NN proprioception)) (, ,) (NP (NN vibration)) (, ,) (CC and) (NP (NN monofilament) (NN sensation) (NN Laboratory) (NN evaluation) (CD •) (NN A1C))))) (, ,) (SBAR (IN if) (NP (NP (NNS results) (RB not)) (ADJP (JJ available)) (PP (IN within) (NP (JJ past) (NP (CD 2)) (: --) (SBAR (NP (CD 3) (NNS months)) (IN If) (S (ADJP (RB not) (JJ performed/available)) (VP (PP (IN within) (NP (NP (JJ past) (NN year) (CD •) (JJ Fasting) (NN lipid) (NN profile)) (, ,) (PP (VBG including) (NP (NP (NP (NN total)) (, ,) (NP (NN LDL)) (CC and) (NP (NN HDL) (NN cholesterol))) (CC and) (NP (NNS triglycerides)))))) (VP (VBP •) (NP (SBAR (S (NP (NN Liver) (NN function) (NNS tests)) (VP (VBP •) (NP (NP (NN Test)) (PP (IN for) (NP (NP (NN urine) (NN albumin) (NN excretion)) (PP (IN with) (NP (NP (NP (NN spot) (NN urine) (NN albumin-to-creatinine) (NN ratio)) (NP (NP (CD •) (NN Serum) (NN creatinine)) (CC and) (NP (VBN calculated) (NN GFR) (CD •) (NN TSH)))) (PP (IN in) (NP (NN type) (CD 1) (NN diabetes))))))))))) (, ,) (NN dyslipidemia) (CC or) (NNS women)) (PP (IN over) (NP (NN age))) (SBAR (S (NP (NP (CD 50) (NNS years)) (NP (NNS Referrals))) (VP (VBP •) (NP (NP (NP (NNP Eye) (NN care) (NN professional)) (PP (IN for) (NP (NP (NP (JJ annual) (JJ dilated) (NN eye) (NN exam)) (NP (CD •) (NNP Family) (NN planning))) (PP (IN for) (NP (NP (NNS women)) (PP (IN of) (NP (NP (JJ reproductive) (NN age)) (NP (NP (CD •) (NNP Registered) (NN dietitian)) (PP (IN for) (NP (NNP MNT) (CD •))))))))))) (NP (NP (NNP DSME) (CD •) (NN Dentist)) (PP (IN for) (NP (JJ comprehensive) (JJ periodontal) (NN examination) (CD •) (JJ Mental) (NN health) (NN professional))))) (, ,) (SBAR (IN if) (S (VP (VBN needed) (VP (X (SYM *)) (S (VP (VB See) (NP (JJ appropriate) (NNS referrals)) (PP (IN for) (NP (DT these) (NNS categories)))))))))))))))))))))))))))))))))))))))) (. .)))
(ROOT (LST (LS 1) (. .)))
(ROOT (S (S (NP (NP (NNP Assessment)) (PP (IN of) (NP (JJ glycemic) (NN control))) (NP (CD Two) (JJ primary) (NNS techniques))) (VP (VBP are) (ADJP (JJ available) (SBAR (IN for) (S (NP (NP (NN health) (NNS providers)) (CC and) (NP (NNS patients))) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (NN management) (NN plan))) (PP (IN on) (NP (JJ glycemic) (NN control))))))))))) (: :) (NP (NP (NP (NN patient) (NN self-monitoring)) (PP (IN of) (NP (NP (NP (NN blood) (NN glucose)) (PRN (-LRB- -LRB-) (NP (NN SMBG)) (-RRB- -RRB-))) (CC or) (NP (JJ interstitial) (NN glucose))))) (, ,) (CC and) (NP (NN A1C))) (. .)))
(ROOT (IN a.))
(ROOT (S (NP (NP (NP (NN c) (JJ Continuous) (NN glucose) (NN monitoring)) (PRN (-LRB- -LRB-) (NP (NN CGM)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (JJ intensive) (NN insulin) (NNS regimens)))))) (VP (MD can) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN tool)) (PP (TO to) (NP (NP (JJR lower) (NN A1C)) (PP (IN in) (NP (NP (VBN selected) (NNS adults)) (PRN (-LRB- -LRB-) (NP (JJ aged) (JJR >) (JJ =) (CD 25) (NNS years)) (-RRB- -RRB-)))))) (PP (IN with) (NP (NN type) (CD 1) (NN diabetes)))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (NP (NP (NN c)) (SBAR (IN Although) (S (NP (NP (DT the) (NN evidence)) (PP (IN for) (NP (NN A1C) (NN lowering)))) (VP (VBZ is) (S (ADJP (RBR less) (JJ strong)) (PP (IN in) (NP (NP (NNS children)) (, ,) (NP (NNS teens)) (, ,) (CC and) (NP (JJR younger) (NNS adults)))) (, ,) (NP (NNP CGM)) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (PP (IN in) (NP (DT these) (NNS groups)))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))
(ROOT (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP are) (NP (JJ few) (JJ rigorous) (NNS studies))))) (, ,) (S (NP (NP (DT a) (NN database) (NN study)) (PP (IN of) (NP (NP (QP (RB almost) (CD 27,000)) (NNS children)) (CC and) (NP (NNS adolescents)))) (PP (IN with) (NP (NN type) (CD 1) (NN diabetes)))) (VP (VBD showed) (SBAR (IN that) (, ,) (S (PP (IN after) (NP (NP (NN adjustment)) (PP (IN for) (NP (JJ multiple) (NNS confounders))))) (, ,) (NP (NP (VBD increased) (JJ daily) (NN frequency)) (PP (IN of) (NP (NN SMBG)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN associated) (PP (PP (IN with) (NP (NP (JJR lower) (NN A1C)) (PRN (-LRB- -LRB-) (NP (NP (CD 20.2) (NN %)) (PP (IN per) (NP (JJ additional) (NN test))) (PP (IN per) (NP (NN day))) (, ,) (VP (VBG leveling) (PRT (RP off)) (PP (IN at) (NP (NP (CD five) (NNS tests)) (PP (IN per) (NP (NN day))))))) (-RRB- -RRB-)))) (CC and) (PP (IN with) (NP (NP (JJR fewer) (JJ acute) (NNS complications)) (PRN (-LRB- -LRB-) (NP (CD 57)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (S (NP (DT A) (JJ recent) (NN meta-analysis)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNP SMBG)) (VP (VBD reduced) (NP (NN A1C)) (PP (IN by) (NP (CD 0.25) (NN %))) (PP (IN at) (NP (NP (CD 6) (NNS months)) (PRN (-LRB- -LRB-) (NP (CD 61)) (-RRB- -RRB-))))))) (, ,) (SBAR (IN while) (S (NP (DT a) (NNP Cochrane) (NN review)) (VP (VBD concluded) (SBAR (IN that) (S (NP (NP (DT the) (JJ overall) (NN effect)) (PP (IN of) (NP (NN SMBG))) (PP (IN in) (NP (JJ such) (NNS patients)))) (VP (VBZ is) (ADJP (JJ small)) (PP (NP (QP (IN up) (TO to) (CD 6)) (NNS months)) (IN after) (NP (NP (NN initiation)) (CC and) (NP (NNS subsides)))) (PP (IN after) (NP (NP (CD 12) (NNS months)) (PRN (-LRB- -LRB-) (NP (CD 62)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (CD one) (NN study)) (PP (IN of) (NP (NP (JJ insulin-naïve) (NNS patients)) (PP (IN with) (NP (JJ suboptimal) (JJ initial) (JJ glycemic) (NN control))))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ structured) (NN SMBG)) (PRN (-LRB- -LRB-) (NP (NP (NP (DT a) (NN paper) (NN tool)) (SBAR (S (VP (TO to) (VP (VB collect)))))) (CC and) (VP (VB interpret) (NP (JJ 7-point) (NN SMBG) (NNS profiles)) (PP (IN over) (NP (CD 3) (NNS days))) (NP (ADVP (IN at) (JJS least)) (JJ quarterly)))) (-RRB- -RRB-))))) (VP (VBD reduced) (NP (NN A1C)) (PP (IN by) (NP (CD 0.3) (NN %))) (ADVP (JJR more) (PP (IN than) (PP (IN in) (NP (NP (DT an) (JJ active) (NN control) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 65)) (-RRB- -RRB-))))))) (. .)))
(ROOT (S (NP (NP (DT A) (JJ 26-week) (JJ randomized) (NN trial)) (PP (IN of) (NP (CD 322) (NN type) (CD 1) (JJ diabetic) (NNS patients)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS adults)) (NP (NP (JJ aged) (JJR >) (JJ =) (CD 25) (NNS years)) (VP (VBG using) (NP (NP (JJ intensive) (NN insulin) (NN therapy)) (CC and) (NP (NNP CGM))))) (VP (VBD experienced) (NP (NP (DT a) (ADJP (CD 0.5) (NN %)) (NN reduction)) (PP (IN in) (NP (NN A1C)))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (CD ~) (NP (QP (CD 7.6) (TO to) (CD 7.1)) (NN %)))) (-RRB- -RRB-)) (PP (VBN compared) (PP (IN with) (NP (NP (JJ usual) (JJ intensive) (NN insulin) (NN therapy)) (PP (IN with) (NP (NP (NN SMBG)) (PRN (-LRB- -LRB-) (NP (CD 66)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (S (S (NP (NP (NN Sensor) (NN use)) (PP (IN in) (NP (NP (NNS children)) (, ,) (NP (NNS teens)) (, ,) (CC and) (NP (NP (NNS adults)) (PP (TO to) (NP (NN age) (CD 24) (NNS years))))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (JJ significant) (NN A1C) (NN lowering)))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (NN hypoglycemia)) (PP (IN in) (NP (DT any) (NN group)))))))) (. .)))
(ROOT (S (ADVP (RB Importantly)) (, ,) (NP (NP (DT the) (JJS greatest) (NN predictor)) (PP (IN of) (NP (NN A1C) (NN lowering))) (PP (IN in) (NP (DT this) (NN study))) (PP (IN for) (NP (DT all) (NNS age-groups)))) (VP (VBD was) (NP (NP (NN frequency)) (PP (IN of) (NP (NP (NN sensor) (NN use)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJR lower)) (PP (IN in) (NP (JJR younger) (NNS age-groups)))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (DT a) (JJR smaller) (NN RCT)) (PP (IN of) (NP (NP (CD 129) (NNS adults)) (CC and) (NP (NP (NNS children)) (SBAR (IN with) (S (NP (NN baseline) (NN A1C)) (NP (QP (JJR <) (CD 7.0)) (NN %))))))))) (, ,) (NP (NP (NNS outcomes)) (VP (VBG combining) (NP (NP (NN A1C)) (CC and) (NP (NN hypoglycemia))))) (VP (VBD favored) (NP (NP (DT the) (NN group)) (VP (VBG utilizing) (NP (NNP CGM)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NNP CGM)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ beneficial)) (PP (IN for) (NP (NP (NNS individuals)) (PP (IN with) (NP (NP (NN type) (CD 1) (NN diabetes)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (ADVP (RB already)) (VP (VBN achieved) (NP (NP (JJ excellent) (NN control)) (PRN (-LRB- -LRB-) (NP (CD 67)) (-RRB- -RRB-))))))))))))))))) (. .)))
(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NNS meta-analyses)) (VP (VBP suggest) (SBAR (IN that) (FRAG (PP (VBN compared) (PP (IN with) (NP (NP (NN SMBG)) (, ,) (S (NP (NNP CGM)) (VP (VBZ lowers) (NP (NN A1C)) (PP (IN by) (NP (NP (NN ~) (CD 0.26) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 70)) (-RRB- -RRB-)))))))))))) (. .)))
(ROOT (S (ADVP (RB Altogether)) (, ,) (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (, ,) (S (PP (IN in) (NP (RB appropriately) (VBN selected) (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN motivated) (S (VP (TO to) (VP (VB wear) (NP (PRP it)) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN time))))))))))) (, ,) (NP (NNP CGM)) (VP (VBZ reduces) (NP (NN A1C)))))) (. .)))
(ROOT (S (S (NP (NP (DT A) (NN trial)) (VP (VBG comparing) (NP (NP (NNP CGM)) (CC plus) (NP (NN insulin) (NN pump))) (PP (TO to) (NP (NP (NN SMBG)) (CC plus) (NP (NP (JJ multiple) (NNS injections)) (PP (IN of) (NP (NN insulin))) (PP (IN in) (NP (NP (NNS adults)) (CC and) (NP (NP (NNS children)) (PP (IN with) (NP (NN type) (CD 1) (NN diabetes))))))))))) (VP (VBD showed) (NP (NP (ADJP (RB significantly) (JJR greater)) (NNS improvements)) (PP (IN in) (NP (NP (NN A1C)) (PP (IN with) (NP (NP (`` ``) (JJ sensoraugmented) (NN pump) ('' '') (NN therapy)) (PRN (-LRB- -LRB-) (NP (CD 68,69)) (-RRB- -RRB-))))))))) (, ,) (CC but) (S (NP (DT this) (NN trial)) (VP (VBD did) (RB not) (VP (VB isolate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNP CGM)) (NP (PRP itself)))))))) (. .)))
(ROOT (S (S (NP (NN A1C) (NNS Recommendations)) (VP (VBP •) (VP (VB Perform) (NP (DT the) (NN A1C) (NN test)) (NP (NP (ADVP (IN at) (JJS least)) (NP (NP (CD two) (NNS times)) (NP (DT a) (NN year))) (PP (IN in) (NP (NNS patients)))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (NP (NP (NN meeting) (NN treatment) (NNS goals)) (-LRB- -LRB-) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (JJ stable) (JJ glycemic) (NN control))))))))))))) (-RRB- -RRB-) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (ADVP (RB •)) (VP (VB Perform) (NP (DT the) (NN A1C) (NN test)) (ADVP (RB quarterly)) (PP (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP$ whose) (NN therapy)) (S (VP (VBZ has) (VP (VBN changed))))))) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBP are) (RB not) (VP (VBG meeting) (NP (JJ glycemic) (NNS goals)))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (NP (NP (NN •) (NN Use)) (PP (IN of) (NP (NP (NN POC) (NN testing)) (PP (IN for) (NP (NN A1C)))))) (VP (VBZ provides) (NP (NP (DT the) (NN opportunity)) (PP (IN for) (NP (ADJP (JJR more) (JJ timely)) (NN treatment) (NNS changes))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (S (S (PP (IN For) (NP (DT any) (JJ individual) (NN patient))) (, ,) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN A1C) (NN testing)))) (VP (MD should) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (JJ clinical) (NN situation))))))) (, ,) (NP (DT the) (NN treatment) (NN regimen)) (VP (VBN used))) (, ,) (CC and) (NP (NP (DT the) (NN judgment)) (PP (IN of) (NP (DT the) (NN clinician)))) (. .)))
(ROOT (S (NP (NP (DT The) (NN availability)) (PP (IN of) (NP (DT the) (NN A1C) (NN result))) (PP (IN at) (NP (NP (DT the) (NN time)) (SBAR (WHADVP (IN that)) (S (NP (DT the) (NN patient)) (VP (VBZ is) (VP (VBN seen) (PRN (-LRB- -LRB-) (NP (NN POC) (NN testing)) (-RRB- -RRB-))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (JJ small) (NNS studies)) (SBAR (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (NP (NP (VBN increased) (NN intensification)) (PP (IN of) (NP (NN therapy)))) (CC and) (NP (NN improvement))) (PP (IN in) (NP (NP (JJ glycemic) (NN control)) (PRN (-LRB- -LRB-) (NP (CD 73,74)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (NP (CD two) (JJ recent) (JJ systematic) (NNS reviews) (CC and) (NNS meta-analyses)) (VP (VBD found) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NN A1C))) (PP (IN between) (NP (NP (NN POC)) (CC and) (NP (NP (NN laboratory) (NN A1C) (NN usage)) (PRN (-LRB- -LRB-) (NP (CD 75,76)) (-RRB- -RRB-))))))) (. .)))
(ROOT (S (SBAR (IN Because) (S (NP (NN A1C)) (VP (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB reflect) (NP (NP (JJ average) (NN glycemia)) (PP (IN over) (NP (NP (JJ several) (NNS months)) (PRN (-LRB- -LRB-) (NP (CD 63)) (-RRB- -RRB-)))))))))) (CC and) (VP (VBZ has) (NP (NP (JJ strong) (JJ predictive) (NN value)) (PP (IN for) (NP (NP (NN diabetes) (NNS complications)) (PRN (-LRB- -LRB-) (NP (CD 71,72)) (-RRB- -RRB-))))))))) (, ,) (NP (NN A1C) (NN testing)) (VP (MD should) (VP (VB be) (VP (VBN performed) (ADVP (RB routinely)) (PP (IN in) (NP (NP (DT all) (NNS patients)) (PP (IN with) (NP (NN diabetes))))) (, ,) (PP (PP (IN at) (NP (JJ initial) (NN assessment))) (CC and) (ADVP (RB then))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (VBG continuing) (NN care)))))))) (. .)))
(ROOT (S (NP (DT The) (NN A1C) (NN test)) (VP (VBZ is) (ADJP (JJ subject) (PP (TO to) (NP (JJ certain) (NNS limitations))))) (. .)))
(ROOT (NP (NP (NP (NNS Conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (SBAR (S (NP (NP (NP (NN erythrocyte) (NN turnover)) (PRN (-LRB- -LRB-) (NP (NP (NN hemolysis)) (, ,) (NP (NN blood) (NN loss))) (-RRB- -RRB-))) (CC and) (NP (NN hemoglobin) (NNS variants))) (VP (MD must) (VP (VB be) (VP (VBN considered) (, ,) (SBAR (ADVP (RB particularly)) (WHADVP (WRB when)) (S (NP (DT the) (NN A1C) (NN result)) (VP (VBZ does) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NP (DT the) (NN patient) (POS 's)) (JJ clinical) (NN situation)) (PRN (-LRB- -LRB-) (NP (CD 63)) (-RRB- -RRB-))))))))))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN A1C)) (VP (VBZ does) (RB not) (VP (VB provide) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (JJ glycemic) (NN variability)) (CC or) (NP (NN hypoglycemia))))))) (. .)))
(ROOT (S (PP (IN For) (NP (NP (NP (NNS patients)) (ADJP (JJ prone) (PP (TO to) (NP (JJ glycemic) (NN variability))))) (PRN (-LRB- -LRB-) (PP (RB especially) (NP (NP (NN type) (CD 1) (JJ diabetic) (NNS patients)) (CC or) (NP (NP (NN type) (CD 2) (JJ diabetic) (NNS patients)) (PP (IN with) (NP (JJ severe) (NN insulin) (NN deficiency)))))) (-RRB- -RRB-)))) (, ,) (NP (JJ glycemic) (NN control)) (VP (VBZ is) (ADJP (JJS best) (VBN judged) (PP (IN by) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NNS results)) (PP (IN of) (NP (NP (NN self-monitoring)) (CC and) (NP (DT the) (NN A1C)))))))))) (. .)))
(ROOT (S (NP (DT The) (NN A1C)) (VP (MD may) (ADVP (RB also)) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN check)) (PP (IN on) (NP (NP (DT the) (NN accuracy)) (PP (IN of) (NP (NP (NP (NP (DT the) (NN patient) (POS 's)) (NN meter)) (PRN (-LRB- -LRB-) (CC or) (NP (NP (DT the) (NN patient) (POS 's)) (VBN reported) (NN SMBG) (NNS results)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN adequacy)) (PP (IN of) (NP (DT the) (NN SMBG) (NN testing) (NN schedule)))))))))))) (. .)))
(ROOT (NP (NP (NNP Table) (CD 8) (VP (VBZ contains) (NP (NP (DT the) (NN correlation)) (PP (IN between) (NP (NP (NN A1C) (NNS levels)) (CC and) (VP (VB mean) (NP (NP (S (S (NP (NP (NN plasma) (NN glucose) (NNS levels)) (PP (VBN based) (PP (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (NP (NP (DT the) (JJ international) (JJ A1C-Derived) (JJ Average) (NN Glucose)) (PRN (-LRB- -LRB-) (NP (NN ADAG)) (-RRB- -RRB-))) (NN trial))))))) (VP (VBG utilizing) (NP (JJ frequent) (NN SMBG)))) (CC and) (S (NP (NP (NP (NNP CGM)) (PP (IN in) (NP (CD 507) (NNS adults)))) (PRN (-LRB- -LRB-) (NP (NP (CD 83) (NN %)) (JJ Caucasian)) (-RRB- -RRB-))) (PP (IN with) (NP (NN type) (CD 1))))) (, ,) (NN type) (CD 2)) (, ,) (CC and) (NP (NP (DT no) (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 77)) (-RRB- -RRB-)))))))))) (. .)))
(ROOT (S (NP (NP (DT The) (NN ADA)) (CC and) (NP (NP (DT the) (NNP American) (NNP Association)) (PP (IN for) (NP (JJ Clinical) (NNP Chemistry))))) (VP (VBP have) (VP (VBN determined) (SBAR (IN that) (S (NP (NP (DT the) (NN correlation)) (PRN (-LRB- -LRB-) (S (NP (NN r)) (VP (JJ =) (NP (CD 0.92)))) (-RRB- -RRB-))) (VP (VBZ is) (SBAR (ADJP (JJ strong) (RB enough) (S (VP (TO to) (VP (VB justify) (S (VP (VBG reporting) (NP (DT both) (NP (DT an) (NN A1C) (NN result)) (CC and) (NP (NP (DT an) (VBN estimated) (JJ average) (NN glucose)) (PRN (-LRB- -LRB-) (NP (NN eAG)) (-RRB- -RRB-)))))))))) (S (VP (VBP result) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN clinician)) (VP (NNS orders) (NP (DT the) (NN A1C) (NN test))))))))))))) (. .)))
(ROOT (NP (NP (DT The) (NN table)) (PP (IN in) (NP (NP (NN pre2009) (NNS versions)) (PP (IN of) (NP (NP (DT the) (`` ``) (NNPS Standards)) (PP (IN of) (NP (NNP Medical) (NNP Care))) (PP (IN in) (NP (NNP Diabetes))))))) ('' '') (S (VP (VBG describing) (NP (NP (DT the) (NN correlation)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (S (VP (VB mean) (SBAR (S (NP (NN glucose)) (VP (VBD was) (VP (VBN derived) (PP (IN from) (NP (NP (NP (ADJP (RB relatively) (JJ sparse)) (NNS data)) (PRN (-LRB- -LRB-) (NP (NP (CD one) (JJ 7-point) (NN profile)) (PP (IN over) (NP (NP (CD 1) (NN day)) (PP (IN per) (NP (NN A1C) (NN reading)))))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (ADJP (RB primarily) (JJ Caucasian)) (NN type) (CD 1) (JJ diabetic) (NNS participants)) (PP (IN in) (NP (NP (DT the) (NNP DCCT)) (PRN (-LRB- -LRB-) (NP (CD 78)) (-RRB- -RRB-))))))))))))))))))) (. .)))
(ROOT (S (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB note) (SBAR (IN that) (S (NP (NP (DT the) (NNS numbers)) (PP (IN in) (NP (DT the) (NN table)))) (VP (VBP are) (ADVP (RB now)) (ADJP (JJ different)))))))) (, ,) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (NP (NN ~) (CD 2,800) (NNS readings)) (PP (IN per) (NP (NN A1C)))) (PP (IN in) (NP (DT the) (NN ADAG) (NN trial))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (DT the) (NN ADAG) (NN trial))) (, ,) (NP (EX there)) (VP (VBD were) (NP (DT no) (JJ significant) (NNS differences)) (PP (IN among) (NP (NP (NP (JJ racial) (CC and) (JJ ethnic) (NNS groups)) (PP (IN in) (NP (DT the) (NN regression) (NNS lines)))) (PP (IN between) (NP (NP (NN A1C)) (CC and) (VP (VB mean) (NP (NP (NN glucose)) (, ,) (SBAR (IN although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN trend)) (PP (IN toward) (NP (NP (DT a) (NN difference)) (PP (IN between) (NP (NP (NNP African/African) (NNP American) (NNS participants)) (CC and) (NP (JJ Caucasian) (NNS ones))))))))))))))))) (. .)))
(ROOT (S (NP (NP (DT A) (JJ small) (NN study)) (VP (VBG comparing) (NP (NN A1C)) (PP (TO to) (NP (NP (NNP CGM) (NNS data)) (PP (IN in) (NP (NN type) (CD 1) (JJ diabetic) (NNS children))))))) (VP (VBD found) (NP (NP (DT a) (ADJP (RB highly) (RB statistically) (JJ significant)) (NN correlation)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (VP (VB mean) (NP (NP (NN blood) (NN glucose)) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN correlation)) (PRN (-LRB- -LRB-) (S (NP (NN r)) (VP (JJ =) (NP (CD 0.7)))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN ADAG) (NN trial)) (PRN (-LRB- -LRB-) (NP (CD 79)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (SBAR (IN Whether) (S (NP (EX there)) (VP (VBP are) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (SBAR (WHADVP (WRB how)) (S (NP (NN A1C)) (VP (VBZ relates) (PP (TO to) (NP (NP (JJ average) (NN glucose)) (PP (PP (IN in) (NP (NNS children))) (CC or) (PP (IN in) (NP (JJ African) (JJ American) (NNS patients)))))))))))))) (VP (VBZ is) (NP (NP (DT an) (NN area)) (PP (IN for) (NP (JJ further) (NN study))))) (. .)))
(ROOT (S (PP (IN For) (NP (DT the) (NN time) (VBG being))) (, ,) (NP (DT the) (NN question)) (VP (VBZ has) (RB not) (VP (VBN led) (PP (PP (TO to) (NP (NP (JJ different) (NNS recommendations)) (PP (IN about) (NP (NN testing) (NN A1C))))) (CC or) (PP (TO to) (NP (NP (JJ different) (NNS interpretations)) (PP (IN of) (NP (NP (DT the) (JJ clinical) (NN meaning)) (PP (IN of) (S (VP (VBN given) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NN A1C)) (PP (IN in) (NP (DT those) (NNS populations)))))))))))))))) (. .)))
(ROOT (S (NP (NP (DT The) (NN correlation)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (JJ average) (NN glucose))))) (VP (VBD was) (FRAG (NP (CD 0.92)) (-LRB- -LRB-) (NP (NP (NN ref))))) (. .)))
(ROOT (FRAG (LST (NP (CD 77)) (-RRB- -RRB-)) (. .)))
(ROOT (S (NP (NP (DT A) (NN calculator)) (PP (IN for) (S (VP (VBG converting) (NP (NN A1C)))))) (VP (VP (VBZ results) (PP (IN into) (NP (NP (NNP eAG)) (, ,) (PP (IN in) (NP (CC either) (NP (NN mg/dL)) (CC or) (NP (NN mmol/L))))))) (, ,) (VP (VBZ is) (ADJP (JJ available) (PP (IN at) (NP (NN http://professional.diabetes.org/eAG)))))) (. .)))
(ROOT (S (NP (NP (NNP Table) (NN 8-Correlation)) (PP (IN of) (NP (NN A1C))) (PP (IN with) (NP (NP (NP (JJ average) (NN glucose) (NN Mean) (NN plasma) (NN glucose) (NN A1C)) (PRN (-LRB- -LRB-) (NP (NN %)) (-RRB- -RRB-))) (NN mg/dL) (NN mmol/L) (QP (CD 6) (CD 126) (CD 7.0) (CD 7) (CD 8) (CD 154) (CD 183)))) (NP (QP (CD 8.6) (CD 10.2) (CD 9) (CD 212) (CD 11.8))) (NP (QP (CD 10) (CD 240) (CD 13.4) (CD 11) (CD 269)) (QP (CD 14.9) (CD 12) (CD 298) (CD 16.5)) (DT These) (NNS estimates))) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (NN ADAG) (NNS data)) (PP (IN of) (NP (: ;) (NP (NP (CD 2,700) (NN glucose) (NNS measurements)) (PP (IN over) (NP (NP (CD 3) (NNS months)) (PP (IN per) (NP (NN A1C)))))) (NN measurement) (PP (IN in) (NP (NP (CD 507) (NNS adults)) (PP (IN with) (NP (NN type) (CD 1))))) (, ,) (NP (NN type) (CD 2) (, ,) (CC and) (NP (DT no) (NN diabetes))))))))) (. .)))
(ROOT (S (PP (IN For) (NP (NP (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (NN A1C/eAG)) (CC and) (NP (VBN measured) (NN blood) (NN glucose))) (VP (VBP appear) (ADJP (JJ discrepant))))))) (, ,) (S (NP (NNS clinicians)) (VP (MD should) (VP (VB consider) (NP (NP (DT the) (NNS possibilities)) (PP (IN of) (NP (NP (NN hemoglobinopathy)) (CC or) (NP (JJ altered) (JJ red) (NN cell) (NN turnover)))))))) (, ,) (CC and) (NP (NP (DT the) (NNS options)) (PP (IN of) (NP (NP (ADJP (ADJP (JJR more) (JJ frequent)) (CC and/or) (ADJP (JJ different))) (NN timing)) (PP (IN of) (NP (NP (NN SMBG)) (CC or) (NP (NP (NN use)) (PP (IN of) (NP (NNP CGM))))))))) (. .)))
(ROOT (S (S (NP (NP (JJ Other) (NNS measures)) (PP (IN of) (NP (NP (JJ chronic) (NN glycemia)) (PP (JJ such) (IN as) (NP (NN fructosamine)))))) (VP (VBP are) (ADJP (JJ available)))) (, ,) (CC but) (S (NP (NP (PRP$ their) (NN linkage)) (PP (TO to) (NP (NP (JJ average) (NN glucose)) (CC and) (NP (PRP$ their) (JJ prognostic) (NN significance))))) (VP (VBP are) (RB not) (ADJP (ADJP (IN as) (JJ clear)) (SBAR (IN as) (SINV (VP (VBZ is)) (NP (NP (DT the) (NN case)) (PP (IN for) (NP (NN A1C))))))))) (. .)))
(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT a) (JJ reasonable) (NN A1C) (NN goal)) (PP (IN for) (NP (JJ many) (JJ nonpregnant) (NNS adults)))) (VP (VBZ is) (NP (QP (JJR <) (CD 7)) (NN %))) (. .)))
(ROOT (S (NP (NP (JJ Glycemic) (NNS goals)) (PP (IN in) (NP (NNS adults) (NNS Recommendations)))) (VP (VBP •) (S (VP (VBG Lowering) (NP (NN A1C)) (PP (PP (TO to) (PP (IN below))) (CC or) (NP (QP (IN around) (CD 7)) (NN %)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB reduce) (NP (NP (JJ microvascular) (NNS complications)) (PP (IN of) (NP (NN diabetes))))) (CC and) (SBAR (IN if) (S (VP (VBN implemented) (ADVP (RB soon)) (SBAR (IN after) (S (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ long-term) (NN reduction)) (PP (IN in) (NP (JJ macrovascular) (NN disease)))))))))))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (S (NP (NN •) (NNS Providers)) (VP (MD might) (ADVP (RB reasonably)) (VP (VB suggest) (NP (NP (NP (ADJP (RBR more) (JJ stringent)) (NN A1C) (NNS goals)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (QP (JJR <) (CD 6.5)) (NN %))) (-RRB- -RRB-))) (PP (IN for) (NP (VBN selected) (JJ individual) (NNS patients))))))) (, ,) (SBAR (IN if) (S (NP (DT this)) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN without) (NP (NP (JJ significant) (NN hypoglycemia)) (CC or) (NP (NP (JJ other) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NN treatment))))))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))
(ROOT (S (NP (NP (NN •) (RBR Less) (JJ stringent) (NN A1C) (NNS goals)) (PRN (-LRB- -LRB-) (PP (JJ such) (IN as) (NP (QP (JJR <) (CD 8)) (NN %))) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (ADJP (JJ appropriate) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ severe) (NN hypoglycemia)))))))))) (, ,) (NP (NP (NP (JJ limited) (NN life) (NN expectancy)) (, ,) (VP (VBD advanced) (NP (ADJP (ADJP (JJ microvascular)) (CC or) (ADJP (JJ macrovascular))) (NNS complications))) (, ,) (NP (JJ extensive) (NN comorbid) (NNS conditions)) (, ,) (CC and) (NP (NP (NP (DT those)) (PP (IN with) (NP (JJ long-standing) (NN diabetes)))) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (DT the) (JJ general) (NN goal)) (VP (VBZ is) (NP (ADJP (ADJP (JJ difficult) (SBAR (S (VP (TO to) (VP (VB attain) (PP (IN despite) (NP (NN DSME)))))))) (, ,) (ADJP (JJ appropriate))) (NN glucose) (NN monitoring))))))) (, ,) (CC and) (NP (NP (NP (JJ effective) (NNS doses)) (PP (IN of) (NP (JJ multiple) (NN glucose-lowering) (NNS agents)))) (PP (VBG including) (NP (NN insulin))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (S (NP (NP (DT The) (NNP Veterans) (NNP Affairs) (NNP Diabetes) (NNP Trial)) (PRN (-LRB- -LRB-) (NP (NNP VADT)) (-RRB- -RRB-))) (VP (VBD showed) (NP (NP (JJ significant) (NNS reductions)) (PP (IN in) (NP (NN albuminuria)))) (SBAR (IN with) (S (NP (ADJP (ADJP (JJ intensive)) (PRN (-LRB- -LRB-) (NP (VBN achieved) (JJ median) (NN A1C) (CD 6.9) (NN %)) (-RRB- -RRB-)))) (VP (VBN compared) (PP (IN with) (NP (JJ standard) (JJ glycemic) (NN control)))))))) (, ,) (CC but) (S (X (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (NN retinopathy)) (CC and) (NP (NP (NN neuropathy)) (PRN (-LRB- -LRB-) (NP (CD 86,87)) (-RRB- -RRB-)))))))) (. .)))
(ROOT (NP (NP (NP (NP (DT The) (NNP Action)) (PP (IN in) (NP (NP (NNP Diabetes)) (CC and) (NP (JJ Vascular) (NN Disease))))) (: :) (S (NP (NP (NP (NP (NNP Preterax)) (CC and) (NP (NP (NNP Diamicron) (NN MR) (NNP Controlled) (NN Evaluation)) (PRN (-LRB- -LRB-) (NP (NN ADVANCE)) (-RRB- -RRB-)))) (NN study)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ intensive)) (CC versus) (ADJP (JJ standard))) (JJ glycemic) (NN control)) (PP (IN in) (NP (NN type) (CD 2) (NN diabetes)))))) (VP (VBD found) (NP (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN reduction)) (PP (IN in) (NP (NN albuminuria)))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NP (NN neuropathy)) (CC or) (NP (NN retinopathy))))) (, ,) (SBAR (IN with) (S (NP (NP (DT an) (NN A1C) (NN target)) (PP (IN of) (NP (NP (CD ,6.5) (NN %)) (PRN (-LRB- -LRB-) (NP (VBN achieved) (JJ median) (NN A1C) (CD 6.3) (NN %)) (-RRB- -RRB-))))) (VP (VBN compared) (PP (IN with) (S (NP (JJ standard) (NN therapy)) (VP (VBG achieving) (NP (NP (DT a) (JJ median) (NN A1C)) (PP (IN of) (NP (NP (CD 7.0) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 88)) (-RRB- -RRB-)))))))))))))) (. .)))
(ROOT (S (NP (NP (JJ Epidemiological) (NNS analyses)) (PP (IN of) (NP (DT the) (NN DCCT) (CC and) (NN UKPDS) (-LRB- -LRB-) (CD 71,72) (-RRB- -RRB-)))) (VP (VBP demonstrate) (NP (NP (DT a) (JJ curvi-linear) (NN relationship)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (JJ microvascular) (NNS complications)))))) (. .)))
(ROOT (S (NP (DT These) (NNS analyses)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ further) (NN lowering)) (PP (IN of) (NP (NN A1C))) (PP (PP (IN from) (NP (CD 7))) (PP (TO to) (NP (CD 6) (NN %))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ further) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ microvascular) (NNS complications))))))) (, ,) (SBAR (IN albeit) (S (NP (DT the) (JJ absolute) (NN risk) (NNS reductions)) (VP (VBP become) (ADJP (RB much) (JJR smaller)))))))))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (VP (VBN selected) (NP (NP (JJ individual) (NNS patients)) (, ,) (NP (NP (RB especially) (DT those)) (PP (IN with) (NP (NP (JJ little) (NN comorbidity)) (CC and) (NP (NP (JJ long) (NN life) (NN expectancy)) (-LRB- -LRB-) (SBAR (WHNP (WP who)) (S (VP (MD may) (VP (VB reap) (NP (NP (DT the) (NNS benefits)) (PP (IN of) (NP (NP (JJ further) (NN lowering)) (PP (IN of) (NP (NP (NN glycemia)) (PP (IN below) (NP (CD 7) (NN %)))))))))))) (-RRB- -RRB-)))))) (, ,) (VP (MD may) (, ,) (S (PP (VBN based) (PP (IN on) (NP (NP (NN provider) (NN judgment)) (CC and) (NP (NN patient) (NNS preferences))))) (, ,) (VP (VB adopt) (NP (NP (ADJP (RBR more) (JJ intensive)) (JJ glycemic) (NNS targets)) (PRN (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NP (NP (DT an) (NN A1C) (NN target)) (ADJP (JJR <) (NP (CD 6.5) (NN %))))) (-RRB- -RRB-))) (ADVP (ADVP (RB as) (RB long)) (SBAR (IN as) (S (NP (JJ significant) (NN hypoglycemia)) (VP (VBZ does) (RB not) (VP (VB become) (NP (DT a) (NN barrier))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN ACCORD) (NN study)) (VP (VP (VBD enrolled) (NP (NP (NNS participants)) (PP (IN with) (NP (CC either) (VBN known) (NN CVD) (CC or) (QP (CD two) (CC or) (JJR more)) (JJ major) (JJ cardiovascular) (NN risk) (NNS factors))))) (CC and) (VP (VBD randomized) (NP (PRP them)) (PP (TO to) (NP (NP (NP (JJ intensive) (JJ glycemic) (NN control)) (PRN (-LRB- -LRB-) (NP (NP (NN goal) (NN A1C)) (ADJP (JJR <) (NP (CD 6) (NN %)))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ standard) (JJ glycemic) (NN control)) (PRN (-LRB- -LRB-) (NP (NP (NN goal) (NN A1C) (CD 7)) (: --) (NP (CD 8) (NN %))) (-RRB- -RRB-))))))) (. .)))
(ROOT (S (NP (DT The) (NNP ACCORD) (NNS investigators)) (ADVP (RB subsequently)) (VP (VBN published) (NP (NP (JJ additional) (JJ epidemiological) (NNS analyses)) (VP (VBG showing) (NP (NP (DT no) (NN increase)) (PP (IN in) (NP (NP (NN mortality)) (PP (IN in) (NP (NP (DT the) (JJ intensive) (NN arm) (NNS participants)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD achieved) (NP (NN A1C) (NNS levels)) (PP (IN below) (NP (CD 7) (NN %)))) (CC nor) (PP (IN in) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD lowered) (NP (PRP$ their) (NN A1C)) (PP (ADVP (RB quickly)) (IN after) (NP (NN trial) (NN enrollment))))))))))))))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NN fact))) (, ,) (SBAR (IN although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN A1C) (NN level)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (JJ intensive) (NN arm) (NNS participants)) (VP (VBD had) (NP (NP (ADJP (RB significantly) (JJR lower)) (NN mortality)) (PP (IN than) (NP (JJ standard) (NN arm) (NNS participants))))))))))) (, ,) (NP (NP (DT the) (JJS highest) (NN risk)) (PP (IN for) (NP (NN mortality)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (JJ intensive) (NN arm) (NNS participants)) (PP (IN with) (NP (NP (DT the) (JJS highest) (NN A1C) (NNS levels)) (PRN (-LRB- -LRB-) (NP (CD 96)) (-RRB- -RRB-)))))))) (. .)))
(ROOT (PP (IN Unlike) (NP (NP (DT the) (NN case)) (PP (IN with) (NP (NP (DT the) (NNP DCCT) (NN trial)) (, ,) (SBAR (WHADVP (WRB where)) (S (JJR lower) (VP (VBD achieved) (SBAR (S (NP (NN A1C) (NNS levels)) (VP (VBD were) (VP (VBN related) (PP (TO to) (NP (NP (ADJP (RB significantly) (VBN increased)) (NNS rates)) (PP (IN of) (NP (JJ severe) (NN hypoglycemia))))))))) (S (, ,) (PP (IN in) (NP (NNP ACCORD))) (NP (NP (DT every) (ADJP (CD 1) (NN %)) (NN decline)) (PP (IN in) (NP (NP (NN A1C)) (PP (PP (IN from) (NP (NN baseline))) (PP (TO to) (NP (CD 4) (NNS months)))))) (PP (IN into) (NP (DT the) (NN trial)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ severe) (NN hypoglycemia)))))) (PP (IN in) (NP (NP (CC both) (NNS arms)) (PRN (-LRB- -LRB-) (NP (CD 96)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (NP (NP (JJ Intensive) (JJ glycemic) (NN control)) (PRN (-LRB- -LRB-) (PP (TO to) (NP (DT a) (NN goal) (NN A1C))) (NP (NP (QP (JJR <) (CD 6.5)) (NN %)) (CC vs.) (NP (NP (NN treatment)) (PP (TO to) (NP (JJ local) (NNS standards))))) (-RRB- -RRB-))) (ADVP (RB significantly)) (VP (VBD reduced) (NP (DT the) (JJ primary) (NN end) (NN point))) (. .)))
(ROOT (S (NP (DT The) (NNP VADT)) (VP (VBD randomized) (NP (NP (NP (NNS participants)) (PP (IN with) (NP (NN type) (CD 2) (NN diabetes)))) (ADJP (JJ uncontrolled) (PP (IN on) (NP (NP (NN insulin)) (CC or) (NP (NP (NN maximal-dose) (JJ oral) (NNS agents)) (PRN (-LRB- -LRB-) (NP (JJ median) (NN entry) (NN A1C) (CD 9.4) (NN %)) (-RRB- -RRB-))))))) (PP (TO to) (NP (NP (DT a) (NN strategy)) (PP (IN of) (NP (NP (NP (JJ intensive) (JJ glycemic) (NN control)) (PRN (-LRB- -LRB-) (S (NP (NN goal) (NN A1C)) (NP (QP (JJR <) (CD 6.0)) (NN %))) (-RRB- -RRB-))) (CC or) (NP (JJ standard) (JJ glycemic) (NN control)))))) (, ,) (PP (IN with) (NP (NP (DT a) (VBN planned) (NN A1C) (NN separation)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 1.5)) (NN %)))))) (. .)))
(ROOT (S (ADVP (RB Certainly)) (, ,) (NP (NNS providers)) (VP (MD should) (VP (VP (VB be) (ADJP (JJ vigilant)) (PP (IN in) (S (VP (VBG preventing) (NP (NP (JJ severe) (NN hypoglycemia)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ advanced) (NN disease)))))))))) (CC and) (VP (MD should) (RB not) (VP (ADVP (RB aggressively)) (VB attempt) (S (VP (TO to) (VP (VB achieve) (NP (NP (JJ near-normal) (NN A1C) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (PDT such) (DT a) (NN target)) (VP (MD can) (RB not) (VP (VB be) (VP (ADVP (RB safely) (CC and) (ADVP (RB reasonably) (RB easily))) (VBN achieved)))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NNS recommendations)) (VP (VBP are) (PP (VBN based) (PP (IN on) (NP (NP (DT those)) (PP (IN for) (NP (NN A1C) (NNS values)))))) (, ,) (PP (IN with) (NP (NP (VBN listed) (NN blood) (NN glucose) (NNS levels)) (SBAR (WHNP (WDT that)) (S (VP (VBP appear) (S (VP (TO to) (VP (VB correlate) (PP (IN with) (NP (NP (NN achievement)) (PP (IN of) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (QP (JJR <) (CD 7)) (NN %)))))))))))))))) (. .)))
(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (JJ postprandial) (NN hyperglycemia)) (, ,) (PP (IN like) (NP (JJ preprandial) (NN hyperglycemia))) (, ,) (VP (VBZ contributes) (PP (TO to) (NP (JJ elevated) (NN A1C) (NNS levels))) (, ,) (PP (IN with) (NP (NP (PRP$ its) (JJ relative) (NN contribution)) (VP (VBG being) (ADVP (JJR higher)) (PP (IN at) (NP (NN A1C) (NNS levels)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RBR closer) (PP (TO to) (NP (CD 7) (NN %))))))))))))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (NP (NN outcome) (NNS studies)) (VP (VP (VBP have) (ADVP (RB clearly)) (VP (VBN shown) (S (NP (NN A1C)) (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ primary) (NN predictor)) (PP (IN of) (NP (NNS complications))))))))) (, ,) (CC and) (NP (NP (NN landmark) (JJ glycemic) (NN control) (NNS trials)) (ADJP (JJ such) (SBAR (IN as) (S (NP (DT the) (NN DCCT) (CC and) (NN UKPDS)) (VP (VBP relied) (ADVP (RB overwhelmingly)) (PP (IN on) (NP (JJ preprandial) (NN SMBG))))))))) (. .)))
(ROOT (S (NP (NP (DT A) (JJ reasonable) (NN recommendation)) (PP (IN for) (NP (JJ postprandial) (NN testing) (CC and) (NNS targets)))) (VP (VBZ is) (NP (IN that) (PP (IN for) (NP (NP (NNS individuals)) (SBAR (WHNP (WP who)) (S (VP (VP (VBP have) (NP (NP (JJ premeal) (NN glucose) (NNS values)) (PP (IN within) (NP (NN target))))) (CC but) (VP (VBP have) (NP (NP (NN A1C) (NNS values)) (PP (IN above) (NP (NN target)))) (, ,) (S (VP (VBG monitoring) (NP (NP (NP (JJ postprandial) (NN plasma) (NN glucose)) (PRN (-LRB- -LRB-) (NP (NNP PPG)) (-RRB- -RRB-))) (NP (CD 1)) (PRN (: --) (S (NP (NP (CD 2) (NN h)) (PP (IN after) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN meal)) (CC and) (NP (NN treatment)))) (VP (VBN aimed) (PP (IN at) (S (VP (VBG reducing) (NP (NNP PPG) (NNS values)) (PP (TO to) (NP (JJR <) (CD 180) (NN mg/dL)))))))))))) (VP (MD may) (VP (VB help) (NP (JJR lower) (NN A1C))))))))))))))))) (. .)))
(ROOT (S (S (SBAR (IN As) (S (VP (VBZ regards) (NP (NP (NNS goals)) (PP (IN for) (NP (NP (JJ glycemic) (NN control)) (PP (IN for) (NP (NP (NNS women)) (PP (IN with) (NP (NN GDM))))))))))) (, ,) (NP (NP (NNS recommendations)) (PP (IN from) (NP (NP (DT the) (JJ fifth) (NNP International) (NNP Workshop-Conference)) (PP (IN on) (NP (NP (NNP Gestational) (NNP Diabetes) (NNP Mellitus)) (PRN (-LRB- -LRB-) (NP (CD 105)) (-RRB- -RRB-))))))) (VP (VBD were) (S (VP (TO to) (VP (VB target) (NP (NP (JJ maternal) (JJ capillary) (NN glucose) (NNS concentrations)) (PP (IN of) (: :) (NP (NP (CD •) (ADJP (JJ preprandial))) (: :) (NP (NP (NP (NP (NP (JJR <)) (ADJP (JJ =) (NP (CD 95)))) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 5.3) (NN mmol/L)) (-RRB- -RRB-))) (, ,) (CC and) (ADVP (CC either)))))))))) (: :)) (NP (NP (CD •) (JJ 1-h) (NN postmeal)) (: :) (S (NP (NP (NP (NP (NP (NP (NP (JJR <) (JJ =) (CD 140) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 7.8) (NN mmol/L)) (-RRB- -RRB-))) (CC or) (NP (CD •) (JJ 2-h) (NN postmeal))) (: :) (NP (NP (NP (NP (JJR <) (JJ =) (CD 120) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 6.7) (NN mmol/L)) (-RRB- -RRB-))) (PP (IN For) (NP (NP (NNS women)) (PP (IN with) (NP (NP (JJ pre-existing) (NN type) (CD 1)) (CC or) (NP (NN type) (CD 2)) (NP (NP (NN diabetes)) (SBAR (WHNP (WP who)) (S (VP (VBP become) (ADJP (JJ pregnant))))))))))) (, ,) (NP (NP (DT a) (JJ recent) (NN consensus) (NN statement)) (PRN (-LRB- -LRB-) (NP (CD 106)) (-RRB- -RRB-))))) (VP (VBD recommended) (NP (DT the) (VBG following)) (PP (IN as) (NP (JJ optimal) (JJ glycemic) (NNS goals))))) (, ,) (SBAR (IN if) (S (NP (PRP they)) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN without) (NP (JJ excessive) (NN hypoglycemia))))))))) (: :) (NP (NP (CD •) (NN premeal)) (, ,) (NP (NN bedtime)) (, ,) (CC and) (NP (JJ overnight) (NN glucose) (CD 60))) (: --) (NP (NP (NP (CD 99) (NN mg/dL)) (PRN (-LRB- -LRB-) (NP (CD 3.3)) (: --))) (NP (CD 5.4) (NN mmol/L)))) (-RRB- -RRB-) (NP (NP (CD •) (NN peak) (JJ postprandial) (NN glucose) (CD 100)) (: --) (NP (CD 129) (NN mg/dL) (PRN (-LRB- -LRB-) (NP (NP (CD 5.4) (PRN (: --) (NP (CD 7.1) (NN mmol/L)) (-RRB- -RRB-))) (PP (CD •) (NP (NP (NN A1C)) (NP (NP (QP (JJR <) (CD 6.0)) (NN %)) (NP (NNP D.)))))))))))))
(ROOT (S (NP (DT These) (NNS analogs)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (JJR less) (NN hypoglycemia)) (PP (IN with) (NP (NP (JJ equal) (NN A1C)) (VP (VBG lowering) (PP (IN in) (NP (NP (NN type) (CD 1) (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 107,108)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (NP (NP (NNP Table) (NNP 9-Summary)) (PP (IN of) (NP (JJ glycemic) (NNS recommendations))) (PP (IN for) (NP (JJ many) (JJ nonpregnant) (NNS adults))) (PP (IN with) (NP (NP (NN diabetes) (NN A1C)) (NP (QP (JJR <) (CD 7.0)) (NN %)))) (FRAG (X (SYM *)) (NP (NP (JJ Preprandial) (JJ capillary) (NN plasma) (NN glucose) (CD 70)) (: --) (S (VP (PRN (NP (NP (CD 130) (NN mg/dL) (NN *)) (PRN (-LRB- -LRB-) (NP (CD 3.9)) (: --))) (NP (CD 7.2) (NN mmol/L)) (-RRB- -RRB-)) (NP (NP (JJ Peak) (JJ postprandial) (JJ capillary) (NN plasma) (NN glucose) (NN †)) (NP (NP (NP (JJR <) (CD 180) (NN mg/dL) (NN *)) (PRN (-LRB- -LRB-) (ADJP (JJR <) (NP (QP (CD 10.0)) (NN mmol/L))) (-RRB- -RRB-))) (SBAR (S (NP (CD •) (X (SYM *)) (NNS Goals)) (VP (MD should) (VP (VB be) (VP (VBN individualized) (S (VP (VBN based) (PP (IN on) (: :) (NP (NP (CD •) (NN duration)) (PP (IN of) (NP (NP (NN diabetes) (CD •) (NN age/life) (NN expectancy) (CD •) (NN comorbid) (NNS conditions)) (VP (ADVP (RB •)) (VP (VBN known) (SBAR (S (NP (NP (NN CVD)) (CC or) (NP (JJ advanced) (JJ microvascular) (NNS complications))) (VP (VBP •) (SBAR (S (NP (NN hypoglycemia) (NN unawareness) (CD •) (JJ individual) (NN patient) (NNS considerations)) (VP (VBD •) (ADVP (RBR More) (CC or) (S (NP (ADJP (RBR less) (JJ stringent)) (JJ glycemic) (NNS goals)) (VP (MD may) (VP (VB be) (ADJP (JJ appropriate) (PP (IN for) (NP (JJ individual) (NNS patients)))))))) (VP (VBP •) (SBAR (S (NP (JJ Postprandial) (NN glucose)) (VP (MD may) (VP (VB be) (VP (VBN targeted) (SBAR (IN if) (S (NP (NN A1C) (NNS goals)) (VP (VBP are) (NP (NP (DT no) (NN t)) (SBAR (S (NP (PRP me)) (VP (NN t) (PP (IN de) (NP (NP (NN sp) (FW i) (FW te) (FW re)) (SBAR (S (NP (DT a) (NN c)) (VP (UH hi) (S (NP (NN ng) (NN pr)) (VP (SYM e) (S (VP (VB pr) (NP (NP (DT a) (NN nd) (NN ia) (NN l) (NN g) (NN lu) (NN c) (NNS os)) (VP (LS e) (S (VP (VB go) (SBAR (S (NP (DT a) (NNS ls)) (VP (VBP †) (SBAR (S (NP (JJ Postprandial) (NN glucose) (NNS measurements)) (VP (MD should) (VP (VB be) (VP (VBN made) (NP (NP (CD 1)) (: --) (NP (CD 2)) (PP (NP (NN h)) (IN after) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (DT the) (NN meal))))) (, ,) (NP (NP (RB generally) (JJ peak) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN diabetes)))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))) (. .)))
(ROOT (S (SBAR (IN Although) (S (NP (NP (JJS most) (NNS studies)) (PP (IN of) (NP (NP (NNP MDI)) (CC versus) (NP (NN pump) (NN therapy))))) (VP (VBP have) (VP (VBN been) (ADJP (JJ small) (CC and) (PP (IN of) (NP (JJ short) (NN duration)))))))) (, ,) (NP (DT a) (JJ systematic) (NN review) (CC and) (NN meta-analysis)) (VP (VBD concluded) (SBAR (IN that) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (JJ systematic) (NNS differences)) (PP (IN in) (NP (NP (NN A1C) (CC or) (NNS rates)) (PP (IN of) (NP (NP (JJ severe) (NN hypoglycemia)) (PP (IN in) (NP (NP (NNS children)) (CC and) (NP (NNS adults)))))))) (PP (IN between) (NP (NP (DT the) (CD two) (NNS forms)) (PP (IN of) (NP (NP (JJ intensive) (NN insulin) (NN therapy)) (PRN (-LRB- -LRB-) (NP (CD 70)) (-RRB- -RRB-))))))))))) (. .)))
(ROOT (S (NP (NN •)) (PP (IN In) (NP (NP (ADJP (RB newly) (VBN diagnosed)) (NN type) (CD 2) (JJ diabetic) (NNS patients)) (PP (IN with) (NP (NP (ADJP (ADJP (RB markedly) (JJ symptomatic)) (CC and/or) (ADJP (JJ elevated))) (NN blood) (NN glucose) (NNS levels)) (CC or) (NP (NN A1C)))))) (, ,) (VP (VBP consider) (NP (NP (NN insulin) (NN therapy)) (, ,) (PP (PP (PP (IN with)) (CC or) (PP (IN without))) (NP (NP (JJ additional) (NNS agents)) (, ,) (PP (IN from) (NP (DT the) (NN outset))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (NP (NP (NN •)) (SBAR (IN If) (S (NP (NP (JJ noninsulin) (NN monotherapy)) (PP (IN at) (NP (JJ maximal) (VBN tolerated) (NN dose)))) (VP (VBZ does) (RB not) (VP (VB achieve) (CC or) (VB maintain) (NP (DT the) (NN A1C) (NN target)) (PP (IN over) (NP (NP (CD 3)) (: --) (NP (CD 6) (NNS months)) (, ,))) (VP (VB add) (NP (NP (DT a) (JJ second) (JJ oral) (NN agent)) (, ,) (NP (NP (NP (DT a) (JJ glucagon-like) (NN peptide-1)) (PRN (-LRB- -LRB-) (NP (NN GLP-1)) (-RRB- -RRB-))) (NN receptor) (NN agonist)) (, ,) (CC or) (NP (NN insulin)))))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-)))
(ROOT (S (NP (NP (JJ Comparative) (NN effectiveness) (NNS meta-analyses)) (PRN (-LRB- -LRB-) (NP (CD 112)) (-RRB- -RRB-))) (VP (VBP suggest) (SBAR (S (SBAR (IN that) (S (NP (NP (JJ overall) (NP (DT each) (JJ new) (NN class))) (PP (IN of) (NP (JJ noninsulin) (NNS agents)))) (VP (VBD added) (PP (TO to) (NP (JJ initial) (NN therapy)))))) (VP (VBZ lowers) (NP (NN A1C)) (PP (IN around) (NP (CD 0.9))) (PRN (: --) (NP (CD 1.1) (NN %))))))) (. .)))
(ROOT (S (NP (NP (JJ Clinical) (NN trials/outcome) (NNS studies)) (PP (IN of) (NP (NNP MNT)))) (VP (VBP have) (VP (VBN reported) (NP (NP (NNS decreases)) (PP (IN in) (NP (NN A1C)))) (PP (IN at) (NP (NP (CD 3)) (: --) (NP (NP (CD 6) (NNS months)) (VP (VBG ranging) (PP (PP (IN from) (NP (CD 0.25))) (PP (TO to) (NP (NP (CD 2.9) (NN %)) (PP (IN with) (NP (NP (JJR higher) (NNS reductions)) (VP (VBN seen) (PP (IN in) (NP (NP (NN type) (CD 2) (NN diabetes)) (PP (IN of) (NP (JJR shorter) (NN duration))))))))))))))))) (. .)))
(ROOT (S (NP (JJ Multiple) (NNS studies)) (VP (VBP have) (VP (VP (VBN demonstrated) (NP (NP (JJ sustained) (NNS improvements)) (PP (IN in) (NP (NP (NN A1C)) (PP (IN at) (NP (CD 12) (NNS months))))))) (CC and) (VP (JJR longer) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (VBN registered) (NN dietitian)) (VP (VBD provided) (NP (NP (JJ follow-up) (NNS visits)) (VP (VBG ranging) (NP (ADJP (IN from) (JJ monthly) (PP (TO to) (NP (NP (CD 3) (NNS sessions)) (PP (IN per) (NP (NN year))) (PRN (-LRB- -LRB-) (NP (CD 115)) (: --)) (NP (CD 122))))) (-RRB- -RRB-)))))))))) (. .)))
(ROOT (S (S (PP (IN For) (NP (NP (NNS individuals)) (PP (IN with) (NP (NN type) (CD 2) (NN diabetes))))) (, ,) (NP (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (JJ moderate) (NN weight) (NN loss)) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN %)) (PP (IN of) (NP (NN body) (NN weight)))) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (VBN decreased) (NN insulin) (NN resistance)))))))))) (, ,) (VP (VBD improved) (NP (NP (NP (NNS measures)) (PP (IN of) (NP (NP (NN glycemia)) (CC and) (NP (NN lipemia))))) (, ,) (CC and) (NP (VBN reduced) (NN blood) (NN pressure) (-LRB- -LRB-) (CD 134) (-RRB- -RRB-)))) (: ;) (S (NP (NP (JJ longerterm) (NNS studies)) (PRN (-LRB- -LRB-) (NP (JJR >) (JJ =) (CD 52) (NNS weeks)) (-RRB- -RRB-))) (VP (VBD showed) (SBAR (S (NP (NP (JJ mixed) (NNS effects)) (PP (IN on) (NP (NN A1C))) (PP (PP (IN in) (NP (NP (NNS adults)) (PP (IN with) (NP (NP (NN type) (CD 2) (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 135) (PRN (: --) (NP (CD 137)) (-RRB- -RRB-))) (, ,)))))) (CC and) (PP (IN in) (NP (DT some) (NNS studies) (NNS results))))) (VP (VBD were) (VP (VBN confounded) (PP (IN by) (NP (JJ pharmacological) (NN weight) (NN loss) (NN therapy))))))))) (. .)))
(ROOT (S (NP (NP (JJ One-year) (NNS results)) (PP (IN of) (NP (NP (DT the) (JJ intensive) (NN lifestyle) (NN intervention)) (PP (IN in) (NP (DT this) (NN trial)))))) (VP (VBP show) (NP (NP (DT an) (JJ average) (ADJP (CD 8.6) (NN %)) (NN weight) (NN loss)) (, ,) (NP (NP (JJ significant) (NN reduction)) (PP (IN of) (NP (NN A1C)))) (, ,) (CC and) (NP (NP (NN reduction)) (PP (IN in) (NP (NP (JJ several) (NN CVD) (NN risk) (NNS factors)) (PRN (-LRB- -LRB-) (NP (CD 138)) (-RRB- -RRB-))))) (, ,) (PP (IN with) (NP (NP (NNS benefits)) (VP (VBN sustained) (PP (IN at) (NP (NP (CD 4) (NNS years)) (PRN (-LRB- -LRB-) (NP (CD 139)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (S (NP (NP (NN Evidence)) (PP (IN for) (NP (NP (DT the) (NNS benefits)) (PP (IN of) (NP (NP (NN DSME)) (CC and) (NP (NNP DSMS) (JJ Multiple) (NNS studies))))))) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (NN DSME)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (VBN improved) (NN diabetes) (NN knowledge)) (CC and) (VP (VBD improved) (NP (NP (JJ self-care) (NN behavior)) (PRN (-LRB- -LRB-) (NP (CD 146)) (-RRB- -RRB-))))))))))))) (, ,) (VP (VBD improved) (NP (NP (JJ clinical) (NNS outcomes)) (PP (JJ such) (IN as) (NP (NP (NP (JJR lower) (NN A1C)) (PRN (-LRB- -LRB-) (NP (NP (CD 147,148,150,151,155)) (: --) (NP (CD 158))) (-RRB- -RRB-))) (, ,) (NP (NP (JJR lower) (JJ self-reported) (NN weight)) (PRN (-LRB- -LRB-) (NP (CD 146)) (-RRB- -RRB-))) (, ,)))) (VP (VBD improved) (NP (NP (NN quality)) (PP (IN of) (NP (NP (NN life)) (PRN (-LRB- -LRB-) (NP (CD 149,156,159)) (-RRB- -RRB-))))) (, ,) (NP (NP (NP (JJ healthy) (NN coping)) (PRN (-LRB- -LRB-) (NP (CD 160)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJR lower) (NNS costs)) (PRN (-LRB- -LRB-) (NP (CD 161)) (-RRB- -RRB-)))))) (. .)))
(ROOT (S (NP (NP (VBN Structured) (NN exercise) (NNS interventions)) (PP (IN of) (NP (NP (QP (IN at) (JJS least) (CD 8)) (NNS weeks) (POS ')) (NN duration)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (PP (TO to) (NP (JJR lower) (NN A1C))) (PP (IN by) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (CD 0.66) (NN %))) (PP (IN in) (NP (NP (NNS people)) (PP (IN with) (NP (NN type) (CD 2) (NN diabetes))))))) (, ,) (PP (RB even) (IN with) (NP (NP (DT no) (JJ significant) (NN change)) (PP (IN in) (NP (NP (NN BMI)) (PRN (-LRB- -LRB-) (NP (CD 187)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (NP (NP (JJR Higher) (NNS levels)) (PP (IN of) (NP (NN exercise) (NN intensity)))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (NP (JJR greater) (NNS improvements)) (PP (IN in) (NP (NN A1C)))) (CC and) (PP (IN in) (NP (NN fitness) (PRN (-LRB- -LRB-) (NP (CD 188)) (-RRB- -RRB-)))))))) (. .)))
(ROOT (S (NP (JJ Clinical) (NNS trials)) (VP (VBP have) (VP (VP (VBN provided) (NP (NP (JJ strong) (NN evidence)) (PP (IN for) (NP (NP (DT the) (NN A1C) (VBG lowering) (NN value)) (PP (IN of) (NP (NP (NN resistance) (NN training)) (PP (IN in) (NP (NP (JJR older) (NNS adults)) (PP (IN with) (NP (NP (NN type) (CD 2) (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 192,193)) (-RRB- -RRB-)))))))))))) (CC and) (PP (IN for) (NP (NP (DT an) (JJ additive) (NN benefit)) (PP (IN of) (NP (UCP (JJ combined) (JJ aerobic) (CC and)) (NN resistance) (NN exercise))) (PP (IN in) (NP (NP (NNS adults)) (PP (IN with) (NP (NP (NN type) (CD 2) (NN diabetes)) (PRN (-LRB- -LRB-) (NP (CD 194,195)) (-RRB- -RRB-)))))))))) (. .)))
(ROOT (NP (NP (DT A) (JJ systematic) (NN review) (CC and) (NN meta-analysis)) (SBAR (VBD showed) (IN that) (NP (NP (JJ psychosocial) (NNS interventions)) (ADVP (ADVP (RB modestly)) (CC but) (S (ADVP (RB significantly)) (VP (VBD improved) (NP (NP (NP (NN A1C)) (PRN (-LRB- -LRB-) (NP (NP (JJ standardized) (NN mean) (NN difference)) (NP (CD 20.29) (NN %))) (-RRB- -RRB-))) (CC and) (NP (JJ mental) (NN health) (NNS outcomes)))))))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VP (VBD was) (NP (DT a) (JJ limited) (NN association)) (PP (IN between) (NP (NP (DT the) (NNS effects)) (PP (IN on) (NP (NP (NN A1C)) (CC and) (NP (JJ mental) (NN health))))))) (, ,) (CC and) (SBAR (S (NP (DT no) (NN intervention) (NNS characteristics)) (VP (VBD predicted) (NP (NP (NN benefit)) (PP (IN on) (NP (NP (DT both) (NNS outcomes)) (PRN (-LRB- -LRB-) (NP (CD 208)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (SBAR (IN As) (S (VP (VBN described) (PP (IN in) (NP (DT the) (NN Section) (NN V.b.) (CD 2)))))) (, ,) (S (NP (JJ severe) (NN hypoglycemia)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NN mortality)) (PP (IN in) (NP (NP (NNS participants)) (PP (IN in) (NP (CC both) (NP (DT the) (NN standard)) (CC and) (NP (NP (JJ intensive) (NN glycemia) (NNS arms)) (PP (IN of) (NP (DT the) (NN ACCORD) (NN trial))))))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS relationships)) (PP (IN with) (NP (VBN achieved) (NN A1C) (CC and) (NN treatment) (NN intensity)))) (VP (VBD were) (RB not) (ADJP (JJ straightforward)))) (. .)))
(ROOT (S (S (NP (NNP Table) (CD 10)) (VP (VBZ summarizes) (NP (NP (JJ common) (NN treatment) (NNS goals)) (PP (IN for) (NP (NP (NN A1C)) (, ,) (NP (NN blood) (NN pressure))))))) (, ,) (CC and) (NP (NN LDL) (NN cholesterol)) (. .)))
(ROOT (NP (NP (NNP Table) (CD 10) (NNP Summary)) (PP (IN of) (NP (NP (NNS recommendations)) (PP (IN for) (ADJP (ADJP (JJ glycemic)) (, ,) (NP (NP (NN blood) (NN pressure)) (, ,) (CC and) (NP (NP (NN lipid) (NN control)) (PP (IN for) (NP (JJS most) (NNS adults)))) (PP (IN with) (S (NP (NP (NN diabetes) (NN A1C)) (NP (ADJP (QP (JJR <) (CD 7.0)) (NN %)) (NN *) (NN Blood) (NN pressure))) (NP (QP (JJR <) (CD 140/80)) (NN mmHg)) (FRAG (X (SYM **)) (NP (NP (NNPS Lipids) (NN LDL) (NN cholesterol)) (NP (NP (NP (JJR <) (CD 100) (NN mg/dL)) (PRN (-LRB- -LRB-) (ADJP (JJR <) (NP (QP (CD 2.6)) (NN mmol/L))) (-RRB- -RRB-))) (NP (NP (CD †) (NN Statin) (NN therapy)) (PP (IN for) (NP (NP (DT those)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (NP (NNP MI)) (CC or) (NP (NN age)))))) (SBAR (IN over) (S (NP (CD 401) (JJ other) (NN risk) (NNS factors)) (X (SYM *)) (ADVP (RBR More) (CC or) (S (NP (ADJP (RBR less) (JJ stringent)) (JJ glycemic) (NNS goals)) (VP (MD may) (VP (VB be) (ADJP (JJ appropriate) (PP (IN for) (NP (JJ individual) (NNS patients))))))))))))))))))))))) (. .)))
(ROOT (S (S (NP (DT A) (NN meta-analysis)) (VP (VBD reported) (NP (NP (DT a) (JJ significant) (ADJP (CD 0.47) (NN %)) (NN improvement)) (PP (IN in) (NP (NN A1C)))))) (, ,) (CC but) (S (VP (VBD noted) (SBAR (S (NP (NP (JJ multiple) (NNS problems)) (PP (IN with) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (DT the) (VBN published) (NNS studies)))))) (VP (VBD included) (PP (IN in) (NP (NP (DT the) (NN analysis)) (PRN (-LRB- -LRB-) (NP (CD 400)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (PP (IN In) (S (VP (VBG selecting) (NP (JJ glycemic) (NNS goals))))) (, ,) (NP (NP (DT the) (NNS benefits)) (PP (IN on) (NP (NP (JJ long-term) (NN health) (NNS outcomes)) (PP (IN of) (S (VP (VBG achieving) (NP (DT a) (JJR lower) (NN A1C)))))))) (VP (MD should) (VP (VB be) (VP (VBN balanced) (PP (IN against) (NP (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NN hypoglycemia)))) (CC and) (NP (NP (DT the) (JJ developmental) (NNS burdens)) (PP (IN of) (NP (NP (JJ intensive) (NNS regimens)) (PP (IN in) (NP (NP (NNS children)) (CC and) (NP (NN youth)))))))))))) (. .)))
(ROOT (S (NP (UCP (JJ Age-specific) (JJ glycemic) (CC and)) (NN A1C) (NNS goals)) (VP (VBP are) (VP (VBN presented) (PP (IN in) (NP (NNP Table) (CD 15))))) (. .)))
(ROOT (NP (NN b.)))
(ROOT (NP (NP (NP (NNP Table) (CD 15) (NN Plasma) (NN blood) (NN glucose)) (CC and) (NP (NP (NN A1C) (NNS goals)) (PP (IN for) (NP (NN type) (CD 1) (NN diabetes))))) (PP (IN by) (NP (NP (NP (JJ age-group) (NN Plasma) (NN blood) (NN glucose) (NN goal) (NN range)) (PRN (-LRB- -LRB-) (NP (NN mg/dL)) (-RRB- -RRB-))) (NNS Values))) (PP (IN by) (NP (NP (NN age)) (PRN (-LRB- -LRB-) (NP (NNS years)) (-RRB- -RRB-)))) (PP (IN Before) (NP (NP (NNS meals)) (NP (NP (NNP Bedtime)) (PP (: /) (NP (NP (NP (JJ overnight) (NN A1C) (NN Rationale)) (NNPS Toddlers) (CC and) (NNS preschoolers)) (S (-LRB- -LRB-) (NP (NP (NP (CD 0) (: --) (CD 6) (-RRB- -RRB-) (CD 100) (PRN (: --) (QP (CD 180) (CD 110)) (: --))) (NP (CD 200) (JJR <) (ADJP (QP (CD 8.5)) (NN %)) (NN c) (NN Vulnerability))) (PP (TO to) (NP (NN hypoglycemia) (NN c) (NN Insulin) (NN sensitivity) (NN c) (NN Unpredictability))) (S (PP (IN in) (NP (NP (JJ dietary) (NN intake)) (CC and) (NP (JJ physical) (NN activity) (NN c)))) (NP (NP (DT A) (JJR lower) (NN goal)) (PRN (-LRB- -LRB-) (NP (CD ,8.0) (NN %)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ reasonable) (SBAR (IN if) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (NP (NP (NP (NNP School) (NN age)) (PRN (-LRB- -LRB-) (NP (NP (CD 6)) (: --) (NP (CD 12))) (-RRB- -RRB-))) (NP (NP (CD 90)) (: --) (NP (QP (CD 180) (CD 100))) (: --) (NP (NP (NP (CD 180)) (NP (QP (JJR <) (CD 8)) (NN %))) (VP (VBN achieved) (S (PP (IN without) (NP (NP (JJ excessive) (NN hypoglycemia) (CD •) (NN Vulnerability)) (PP (IN of) (NP (NN hypoglycemia) (NN c))))) (NP (NP (DT A) (JJR lower) (NN goal)) (PRN (-LRB- -LRB-) (NP (CD ,7.5) (NN %)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ reasonable) (SBAR (IN if) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (NP (NP (NNS Adolescents)) (CC and) (S (NP (JJ young) (NNS adults)) (-LRB- -LRB-) (NP (NP (CD 13) (: --) (CD 19) (-RRB- -RRB-) (CD 90) (: --) (NP (QP (CD 130) (CD 90))) (: --)) (NP (NP (CD 150) (NP (QP (JJR <) (CD 7.5)) (NN %))) (VP (VBN achieved) (PP (IN without) (NP (NP (NP (JJ excessive) (NN hypoglycemia) (NN •)) (NP (DT A) (JJR lower) (NN goal))) (PRN (-LRB- -LRB-) (NP (CD ,7.0) (NN %)) (-RRB- -RRB-))))))) (VP (VBZ is) (ADJP (JJ reasonable)) (SBAR (IN if) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN achieved) (PP (IN without) (NP (NP (JJ excessive) (NN hypoglycemia) (NN Key) (NNS concepts)) (PP (IN in) (S (VP (VBG setting) (NP (NP (JJ glycemic) (NNS goals)) (: :) (S (S (NP (CD •) (NNS Goals)) (VP (MD should) (VP (VB be) (VP (VBN individualized))))) (CC and) (S (NP (JJR lower) (NNS goals)) (VP (MD may) (VP (VB be) (ADJP (JJ reasonable) (PP (VBN based) (PP (IN on) (NP (JJ benefit-risk) (NN assessment)))))))))))))))))))))))))))))))))))))))))))))))) (. .)))
(ROOT (S (NP (NN c) (JJ Postprandial) (NN blood) (NN glucose) (NNS values)) (VP (MD should) (VP (VB be) (VP (UCP (VBN measured) (SBAR (WHADVP (WRB when)) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN discrepancy)) (PP (IN between) (NP (NP (JJ preprandial) (NN blood) (NN glucose) (NNS values)) (CC and) (NP (NN A1C) (NNS levels)))))))) (CC and)) (S (VP (TO to) (VP (VB help) (S (VP (VB assess) (NP (NN glycemia)) (PP (IN in) (NP (NP (DT those)) (PP (IN on) (NP (NN basal/bolus) (NNS regimens))))))))))))) (. .)))
(ROOT (S (S (NP (NN Preconception) (NN care) (NNS Recommendations)) (VP (VP (VBP •) (SBAR (S (NP (NN A1C) (NNS levels)) (VP (MD should) (VP (VB be) (ADJP (ADJP (RB as) (JJ close) (PP (TO to) (NP (JJ normal)))) (PP (IN as) (ADJP (JJ possible))))))))) (PRN (-LRB- -LRB-) (NP (QP (JJR <) (CD 7)) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT an) (JJ individual) (NN patient)) (PP (IN before) (NP (NN conception)))))) (VP (VBZ is) (VP (VBN attempted))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (NP (JJ Observational) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (FRAG (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS malformations)))) (VP (VBZ increases) (ADVP (RB continuously)) (PP (IN with) (S (VP (VBG increasing) (NP (JJ maternal) (NN glycemia)) (PP (IN during) (NP (DT the) (JJ first) (CD 6)))))))) (: --) (NP (NP (CD 8) (NNS weeks)) (PP (IN of) (NP (NN gestation)))) (, ,) (SBAR (IN as) (S (VP (VBN defined) (PP (IN by) (NP (NN first-trimester) (NN A1C) (NNS concentrations))))))))) (. .)))
(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (DT no) (NN threshold)) (PP (IN for) (NP (NP (NN A1C) (NNS values)) (SBAR (WHPP (IN below) (WHNP (WDT which))) (S (NP (NN risk)) (VP (VBZ disappears) (ADVP (RB entirely)))))))) (. .)))
(ROOT (FRAG (ADVP (RB However)) (, ,) (NP (NP (NN malformation) (NNS rates)) (PP (IN above) (NP (NP (DT the) (CD 1)) (: --) (NP (NP (ADJP (CD 2) (NN %)) (NN background) (NN rate)) (PP (IN of) (NP (JJ nondiabetic) (NNS pregnancies))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN limited) (PP (TO to) (NP (NP (NNS pregnancies)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ first-trimester) (NN A1C) (NNS concentrations)) (VP (VBP are) (NP (NP (QP (JJR >) (CD 1)) (NN %)) (PP (IN above) (NP (DT the) (JJ normal) (NN range)))) (PP (IN for) (NP (DT a) (JJ nondiabetic) (JJ pregnant) (NN woman))))))))))))))) (. .)))
(ROOT (S (S (NP (NNS Goals)) (VP (VBD were) (VP (VBN set) (S (VP (TO to) (VP (VB achieve) (NP (JJ normal) (NN blood) (NN glucose) (NNS concentrations)))))))) (, ,) (CC and) (S (NP (NP (QP (JJR >) (CD 80)) (NN %)) (PP (IN of) (NP (NNS subjects)))) (VP (VBD achieved) (NP (JJ normal) (NN A1C) (NNS concentrations)))) (SBAR (IN before) (S (NP (PRP they)) (VP (VBD became) (ADJP (JJ pregnant))))) (. .)))
(ROOT (S (NP (NP (DT The) (NNS goals)) (PP (IN of) (NP (NN preconception) (NN care)))) (VP (VBP are) (PP (TO to) (NP (NP (LST (LS 1) (-RRB- -RRB-)) (VB involve)) (CC and) (VP (VP (VB empower) (NP (NP (DT the) (NN patient)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (PRP$ her) (NN diabetes))))))) (, ,) (VP (LST (LS 2) (-RRB- -RRB-)) (VP (VB achieve) (SBAR (S (NP (DT the) (JJS lowest) (NN A1C) (NN test)) (VP (VBZ results) (ADJP (JJ possible)) (PP (IN without) (NP (JJ excessive) (NN hypoglycemia)))))))) (, ,) (S (LST (LS 3) (-RRB- -RRB-)) (VP (VB assure) (NP (JJ effective) (NN contraception)) (S (NP (SBAR (IN until) (S (NP (ADJP (ADJP (JJ stable)) (CC and) (ADJP (JJ acceptable))) (NN glycemia)) (VP (VBZ is) (VP (VBN achieved))))) (, ,) (CC and) (LST (LS 4) (-RRB- -RRB-)) (VB identify)) (, ,) (VP (VB evaluate))) (, ,) (CC and) (VP (VB treat) (NP (NP (JJ longterm) (NN diabetes) (NNS complications)) (PP (JJ such) (IN as) (NP (NP (NN retinopathy)) (, ,) (NP (NN nephropathy)) (, ,) (NP (NN neuropathy)) (, ,) (NP (NN hypertension)) (, ,) (CC and) (NP (NP (NN CHD)) (PRN (-LRB- -LRB-) (NP (CD 106)) (-RRB- -RRB-))))))))))))) (. .)))
(ROOT (NP (NP (NP (NN Use)) (PP (IN of) (NP (NN A1C))) (SBAR (IN as) (S (NP (NP (DT a) (JJ screening) (NN test)) (PP (IN for) (NP (NNP CFRD)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))))) (. .)))
(ROOT (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)))
(ROOT (S (NP (NN •)) (VP (VP (VB Consider) (S (VP (VBG obtaining) (NP (NP (DT an) (NN A1C)) (PP (IN on) (NP (NP (NNS patients)) (PP (IN with) (NP (NN diabetes))))))))) (VBD admitted) (PP (TO to) (NP (DT the) (NN hospital))) (SBAR (IN if) (S (NP (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (NN testing)) (PP (IN in) (NP (DT the) (JJ previous) (CD 2)))))) (: --) (CD 3) (NNS months)) (VP (VBZ is) (RB not) (ADJP (JJ available)))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (NP (NN •)) (VP (VB Consider) (S (VP (VBG obtaining) (NP (NP (DT an) (NN A1C)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN risk) (NNS factors))))) (PP (IN for) (NP (NP (JJ undiagnosed) (NN diabetes)) (SBAR (WHNP (WP who)) (S (VP (VBP exhibit) (NP (NN hyperglycemia)) (PP (IN in) (NP (DT the) (NN hospital)))))))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (NP (NP (DT The) (NN difficulty)) (VP (VBG distinguishing) (PP (IN between) (NP (DT the) (JJ second) (CC and) (JJ third) (NNS categories))) (PP (IN during) (NP (DT the) (NN hospitalization))))) (VP (MD may) (VP (VB be) (VP (VBN overcome) (PP (IN by) (S (VP (VBG measuring) (NP (NP (NP (DT an) (NN A1C)) (PP (IN in) (NP (NP (JJ undiagnosed) (NNS patients)) (PP (IN with) (NP (NN hyperglycemia)))))) (, ,) (PP (ADVP (RB as) (RB long)) (IN as) (NP (NP (NNS conditions)) (VP (VBG interfering) (PP (IN with) (NP (NP (NN A1C) (NN utility)) (PRN (-LRB- -LRB-) (NP (NP (NN hemolysis)) (, ,) (NP (NN blood) (NN transfusion))) (-RRB- -RRB-))))))))))))) (VP (VBP have) (RB not) (VP (VBN occurred)))) (. .)))
(ROOT (FRAG (NP (NP (NN A1C) (NNS values)) (SBAR (S (NP (QP (JJR >) (CD 6.5)) (NN %)) (VP (VBP suggest))))) (, ,) (PP (IN in) (NP (JJ undiagnosed) (NNS patients))) (, ,) (SBAR (IN that) (S (NP (NN diabetes)) (VP (VBD preceded) (NP (NP (NN hospitalization)) (PRN (-LRB- -LRB-) (NP (CD 466)) (-RRB- -RRB-)))))) (. .)))
(ROOT (S (NP (NN Mean) (NN A1C)) (ADVP (RB nationally)) (VP (VBZ has) (VP (VBN declined) (PP (IN from) (NP (NP (CD 7.82) (NN %)) (PP (IN in) (NP (CD 1999))))) (PRN (: --) (NP (NP (NP (CD 2000)) (PP (TO to) (NP (CD 7.18) (NN %))) (PP (IN in) (NP (CD 2004)))) (PP (VBN based) (PP (IN on) (NP (NP (NNP NHANES) (NNS data)) (PRN (-LRB- -LRB-) (NP (CD 495)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (SBAR (ADVP (RB Nevertheless)) (S (S (PP (IN in) (NP (DT some) (NNS studies))) (NP (NP (QP (RB only) (CD 57.1)) (NN %)) (PP (IN of) (NP (NP (NNS adults)) (PP (IN with) (NP (VBN diagnosed) (NN diabetes)))))) (VP (VBD achieved) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (QP (JJR <) (CD 7)) (NN %)))))) (, ,) (S (NP (QP (RB only) (CD 45.5)) (NN %)) (VP (VBD had) (NP (NP (DT a) (NN blood) (NN pressure)) (NP (QP (JJR <) (CD 130/80)) (NN mmHg))))) (, ,) (CC and) (S (NP (QP (RB just) (CD 46.5)) (NN %)) (VP (VBD had) (NP (NP (DT a) (JJ total) (NN cholesterol)) (NP (NP (JJR <) (CD 200) (NN mg/dL)) (, ,) (PP (IN with) (NP (NP (QP (RB only) (CD 12.2)) (NN %)) (PP (IN of) (NP (NP (NNS people)) (PP (IN with) (NP (NP (NN diabetes)) (VP (VBG achieving) (NP (DT all) (CD three) (NN treatment) (NNS goals) (PRN (-LRB- -LRB-) (NP (CD 496)) (-RRB- -RRB-))))))))))))))) (. .)))
(ROOT (S (S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (JJ steady) (NN improvement)) (PP (IN in) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (JJ diabetic) (NNS patients))))) (VP (VBG achieving) (NP (NP (VBN recommended) (NNS levels)) (PP (IN of) (NP (NP (NN A1C)) (, ,) (NP (NN blood) (NN pressure))))))))) (, ,) (CC and) (NP (NP (NP (NN LDL) (NN cholesterol)) (PP (IN in) (NP (DT the) (JJ last) (CD 10) (NNS years)))) (, ,) (PP (CC both) (PP (IN in) (NP (JJ primary) (NN care) (NNS settings))) (CC and) (PP (IN in) (NP (JJ endocrinology) (NNS practices))))) (. .)))
(ROOT (S (NP (NP (NP (NNS Strategies)) (PP (JJ such) (IN as) (NP (NP (JJ explicit) (NN goal) (NN setting)) (PP (IN with) (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 504)) (-RRB- -RRB-))))))) (: ;) (S (VP (VBG identifying) (CC and) (S (VP (VBG addressing) (NP (NP (NN language)) (, ,) (NP (NN numeracy)) (, ,) (CC or) (NP (NP (JJ cultural) (NNS barriers)) (SBAR (S (VP (TO to) (VP (VB care) (PRN (-LRB- -LRB-) (NP (NP (CD 505)) (: --) (NP (CD 508))) (-RRB- -RRB-)))))))))))) (: ;) (VP (VP (VBG integrating) (NP (NP (JJ evidence-based) (NNS guidelines)) (CC and) (NP (JJ clinical) (NN information) (NNS tools))) (PP (IN into) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NN care)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 509)) (: --) (NP (CD 511))) (-RRB- -RRB-))) (: ;) (CC and) (VP (VBG incorporating) (NP (NP (NN care) (NN management) (NNS teams)) (PP (VBG including) (NP (NP (NNS nurses)) (, ,) (NP (NNS pharmacists)) (, ,) (CC and) (NP (NP (JJ other) (NNS providers)) (PRN (-LRB- -LRB-) (NP (NP (CD 512)) (: --) (NP (CD 515))) (-RRB- -RRB-)))))))) (VP (VBP have) (DT each) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB optimize) (NP (NP (NN provider)) (CC and) (NP (NN team) (NN behavior)))) (CC and) (S (ADVP (RB thereby)) (VP (VBP catalyze) (NP (NP (NP (NP (NN reduction)) (PP (IN in) (NP (NN A1C)))) (, ,) (NP (NN blood) (NN pressure))) (, ,) (CC and) (NP (NN LDL) (NN cholesterol))))))))))) (. .)))
(ROOT (NP (NP (NNP International) (NNP Expert) (NNP Committee) (NN report)) (PP (IN on) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NN A1C) (NN assay))) (PP (IN in) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes))))))) (. .)))
(ROOT (NP (CD 11) (. .)))
(ROOT (NP (NP (NP (NNP Cowie) (NN CC)) (, ,) (NP (NNP Rust) (NNP KF)) (, ,) (NP (NNP Byrd-Holt) (NNP DD)) (, ,) (FW et) (NP (FW al.))) (. .)))
(ROOT (NP (NP (NP (NP (NN Prevalence)) (PP (IN of) (NP (NN diabetes)))) (CC and) (NP (NP (JJ high) (NN risk)) (PP (IN for) (NP (NN diabetes))))) (S (VP (VBG using) (NP (NP (NN A1C) (NNS criteria)) (PP (IN in) (NP (DT the) (NNP U.S.) (NN population)))) (PP (IN in) (NP (CD 1988-2006))))) (. .)))
(ROOT (NP (CD 15) (. .)))
(ROOT (FRAG (NP (NP (NP (NNP Zhang) (NNP X)) (, ,) (NP (NNP Gregg) (NNP EW)) (, ,) (NP (NNP Williamson) (NNP DF)) (, ,)) (ADVP (FW et) (FW al.))) (. .)))
(ROOT (NP (NP (NP (NP (NN A1C) (NN level)) (CC and) (NP (NP (JJ future) (NN risk)) (PP (IN of) (NP (NN diabetes))))) (: :) (NP (DT a) (JJ systematic) (NN review))) (. .)))
(ROOT (NP (CD 65) (. .)))
(ROOT (NP (NP (NP (NNP Polonsky) (NNP WH)) (, ,) (NP (NN fisher) (NN L)) (, ,) (NP (NNP Schikman) (NN CH)) (, ,) (FW et) (FW al.)) (. .)))
(ROOT (NP (S (NP (NP (VBN Structured) (NN self-monitoring)) (PP (IN of) (NP (NN blood) (NN glucose)))) (VP (ADVP (RB significantly)) (VBZ reduces) (NP (NN A1C) (NNS levels)) (PP (IN in) (NP (ADJP (ADJP (RB poorly) (VBN controlled)) (, ,) (ADJP (JJ noninsulin-treated))) (NN type) (CD 2) (NN diabetes)))) (: :)) (NP (NP (NNS results)) (PP (IN from) (NP (DT the) (NNP Structured) (NNP Testing) (NNP Program) (NN study)))) (. .)))
(ROOT (NP (CD 77) (. .)))
(ROOT (NP (NP (NNP Nathan) (NN DM)) (, ,) (NP (NN Kuenen) (NN J)) (, ,) (NP (NNP Borg) (NNP R)) (, ,) (NP (NNP Zheng) (NNP H)) (, ,) (NP (NP (NNP Schoenfeld) (NNP D)) (, ,) (NP (NNP Heine) (NN RJ))) (: ;) (NP (JJ A1C-Derived) (JJ Average) (NN Glucose) (NNP Study) (NNP Group)) (. .)))
(ROOT (S (VP (VBG Translating) (NP (DT the) (NN A1C) (NN assay)) (PP (IN into) (NP (VBN estimated) (JJ average) (NN glucose) (NNS values)))) (. .)))
(ROOT (NP (NP (NP (NN Relationship)) (PP (IN of) (NP (NN A1C))) (PP (TO to) (NP (NP (NN glucose) (NNS concentrations)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NN type) (CD 1) (NN diabetes)))))))) (: :) (NP (NP (NNS assessments)) (PP (IN by) (S (VP (VBP high-frequency) (NP (NN glucose) (NNS determinations)) (PP (IN by) (NP (NNS sensors))))))) (. .)))
(ROOT (NP (NP (JJ Epidemiologic) (NNS relationships)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (JJ all-cause) (NN mortality)))) (PP (IN during) (NP (NP (DT a) (JJ median) (ADJP (CD 3.4) (NN year)) (NN follow-up)) (PP (IN of) (NP (NP (JJ glycemic) (NN treatment)) (PP (IN in) (NP (DT the) (NN ACCORD) (NN trial))))))) (. .)))
(ROOT (S (PP (IN During) (NP (DT this) (JJ asymptomatic) (NN period))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (S (VP (TO to) (VP (VB demonstrate) (NP (NP (DT an) (NN abnormality)) (PP (IN in) (NP (NN carbohydrate) (NN metabolism)))) (PP (PP (IN by) (NP (NP (NN measurement)) (PP (IN of) (NP (NP (NN plasma) (NN glucose)) (PP (IN in) (NP (DT the) (JJ fasting) (NN state))))))) (CC or) (PP (IN after) (NP (NP (DT a) (NN challenge)) (PP (IN with) (NP (NP (DT an) (JJ oral) (NN glucose) (NN load)) (CC or) (PP (IN by) (NP (NN A1C)))))))))))) (. .)))
(ROOT (S (SBAR (IN As) (S (NP (NN A1C)) (VP (VBZ is) (VP (VBN used) (ADVP (JJR more) (RB commonly)) (S (VP (TO to) (VP (VB diagnose) (NP (NP (NN diabetes)) (PP (IN in) (NP (NP (NNS individuals)) (PP (IN with) (NP (NN risk) (NNS factors))))))))))))) (, ,) (NP (PRP it)) (VP (MD will) (ADVP (RB also)) (VP (VB identify) (NP (NP (DT those)) (PP (IN at) (NP (NP (JJR higher) (NN risk)) (PP (IN for) (S (VP (VBG developing) (NP (NN diabetes)) (PP (IN in) (NP (DT the) (NN future))))))))))) (. .)))
(ROOT (SBAR (WHADVP (WRB When)) (S (VP (VBG recommending) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN A1C)))) (S (VP (TO to) (VP (VB diagnose) (NP (NN diabetes)) (PP (IN in) (NP (NP (PRP$ its) (CD 2009) (NN report)) (, ,) (S (NP (DT the) (NNP International) (NNP Expert) (NNP Committee)) (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (VP (VP (VBD stressed) (NP (NP (DT the) (NN continuum)) (PP (IN of) (NP (NN risk))) (PP (IN for) (NP (NN diabetes)))) (PP (IN with) (NP (DT all) (JJ glycemic) (NNS measures)))) (CC and) (VP (VBD did) (RB not) (VP (ADVP (RB formally)) (VB identify) (NP (DT an) (JJ equivalent) (JJ intermediate) (NN category)) (PP (IN for) (NP (NN A1C)))))))))))))) (. .)))
(ROOT (SINV (NP (DT The) (NN group)) (VBD did) (NP (NP (NN note) (IN that) (NP (DT those)) (PP (PP (IN with) (NP (NP (NN A1C) (NNS levels)) (SBAR (IN above) (S (NP (DT the) (NN laboratory)) (NP (`` ``) (JJ normal) ('' '') (NN range)))))) (CC but) (PP (IN below) (NP (NP (DT the) (JJ diagnostic) (NN cut) (NN point)) (PP (IN for) (NP (NN diabetes))))))) (PRN (-LRB- -LRB-) (NP (NP (CD 6.0)) (S (VP (TO to) (VP (JJR <) (NP (CD 6.5) (NN %)))))) (-RRB- -RRB-))) (VP (VBP are) (PP (IN at) (NP (NP (ADJP (RB very) (JJ high)) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NN diabetes)))))))) (. .)))
(ROOT (S (ADVP (RB Indeed)) (, ,) (NP (NP (NN incidence)) (PP (IN of) (NP (NN diabetes))) (PP (IN in) (NP (NP (NP (NNS people)) (PP (IN with) (NP (NN A1C) (NNS levels)))) (PP (IN in) (NP (DT this) (NN range)))))) (VP (VBZ is) (NP (NP (QP (JJR more) (IN than) (CD 10) (NNS times)) (IN that)) (PP (IN of) (NP (NP (NNS people)) (PP (IN with) (NP (NP (JJR lower) (NNS levels)) (PRN (-LRB- -LRB-) (NP (CD 4) (PRN (: --) (NP (CD 7)) (-RRB- -RRB-)))))))))) (. .)))
(ROOT (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NP (ADJP (RB nationally) (JJ representative)) (NNS data)) (PP (IN from) (NP (NP (DT the) (NNP National) (NNP Health)) (CC and) (NP (NP (NNP Nutrition) (NNP Examination) (NN Survey)) (PRN (-LRB- -LRB-) (NP (NN NHANES)) (-RRB- -RRB-)))))))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN A1C) (NN value)) (SBAR (WHNP (IN that)) (S (NP (JJS most)) (VP (ADVP (RB accurately)) (VBZ identifies) (NP (NP (NNS people)) (PP (IN with) (NP (NP (NN IFG)) (CC or) (NP (NN IGT))))))))) (VP (VBZ falls) (NP (QP (IN between) (CD 5.5) (CC and) (CD 6.0) (NN %))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ linear) (NN regression) (NNS analyses)) (PP (IN of) (NP (DT these) (NNS data)))) (VP (VBP indicate) (SBAR (IN that) (S (PP (IN among) (NP (DT the) (JJ nondiabetic) (JJ adult) (NN population))) (, ,) (NP (NP (DT an) (NNP FPG)) (PP (IN of) (NP (NP (CD 110) (NN mg/dl)) (PRN (-LRB- -LRB-) (NP (CD 6.1) (NN mmol/l)) (-RRB- -RRB-))))) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.6) (NN %))))) (, ,) (SBAR (IN while) (S (NP (NP (DT an) (NN FPG)) (PP (IN of) (NP (CD 100) (NN mg/dl) (PRN (-LRB- -LRB-) (NP (CD 5.6) (NN mmol/l)) (-RRB- -RRB-))))) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (NP (CD 5.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NNP R.T.) (NNP Ackerman)) (, ,) (NP (JJ personal) (NN communication))) (-RRB- -RRB-))))))))))))) (. .)))
(ROOT (S (S (ADVP (RB finally)) (, ,) (NP (NP (NP (NN evidence)) (PP (IN from) (NP (NP (DT the) (NNP Diabetes) (NNP Prevention) (NNP Program)) (PRN (-LRB- -LRB-) (NP (NNP DPP)) (-RRB- -RRB-))))) (, ,) (WRB wherein) (NP (DT the) (NN mean) (NN A1C))) (VP (VBD was) (NP (NP (CD 5.9) (NN %)) (PRN (-LRB- -LRB-) (S (VP (NN SD) (NP (CD 0.5) (NN %)))) (-RRB- -RRB-)))) (, ,)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ preventive) (NNS interventions)) (VP (VBP are) (ADJP (JJ effective)) (PP (IN in) (NP (NP (NNS groups)) (PP (IN of) (NP (NNS people))) (PP (IN with) (NP (NN A1C) (NNS levels))))) (PP (CC both) (IN below) (CC and) (PP (IN above) (NP (NP (CD 5.9) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (PP (IN For) (NP (DT these) (NNS reasons))) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ appropriate)) (NN A1C) (NN level)) (SBAR (WHPP (IN above) (WHNP (WDT which))) (S (VP (TO to) (VP (VB initiate) (NP (JJ preventive) (NNS interventions))))))) (VP (VBZ is) (ADJP (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (PP (RB somewhere) (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (CD 5.5))))))))) (: --) (NP (CD 6) (NN %)))) (. .)))
(ROOT (S (NP (JJ Prospective) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NP (NNS people)) (PP (IN within) (NP (NP (DT the) (NN A1C) (NN range)) (PP (IN of) (NP (CD 5.5)))))) (: --) (NP (CD 6.0) (NN %)) (VP (VBP have) (NP (NP (DT a) (JJ 5-year) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (NP (NN diabetes)) (SBAR (WHNP (WDT that)) (S (VP (VBZ ranges) (PP (PP (IN from) (NP (CD 12))) (PP (TO to) (NP (NP (CD 25) (NN %)) (PRN (-LRB- -LRB-) (ADJP (ADJP (NP (NP (CD 4) (PRN (: --) (NP (CD 7)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB appreciably)) (PRN (-LRB- -LRB-) (NP (JJ threeto) (JJ eightfold)) (-RRB- -RRB-)))))) (JJR higher)) (PP (IN than) (NP (NP (NP (NN incidence)) (PP (IN in) (NP (DT the) (NNP U.S.) (NN population)))) (PP (IN as) (NP (NP (DT a) (JJ whole)) (PRN (-LRB- -LRB-) (NP (CD 8)) (-RRB- -RRB-)))))))))))))))))))))) (. .)))
(ROOT (S (SBAR (IN As) (S (VP (VBD was) (NP (NP (DT the) (NN case)) (PP (IN with) (NP (NP (NN FPG)) (CC and) (NP (JJ 2-h) (NN PG))))) (, ,) (S (VP (VBG defining) (NP (NP (DT a) (JJR lower) (NN limit)) (PP (IN of) (NP (NP (DT an) (JJ intermediate) (NN category)) (PP (IN of) (NP (NN A1C))))))))))) (VP (VBZ is) (ADJP (RB somewhat) (JJ arbitrary)) (, ,) (SBAR (IN as) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN diabetes))) (PP (IN with) (NP (NP (DT any) (NN measure) (CC or) (NN surrogate)) (PP (IN of) (NP (NN glycemia)))))) (VP (VBZ is) (NP (NP (DT a) (NN continuum)) (, ,) (VP (VBG extending) (ADVP (RB well)) (PP (IN into) (NP (DT the) (JJ normal) (NNS ranges))))))))) (. .)))
(ROOT (S (S (VP (TO To) (VP (VP (VB maximize) (NP (NN equity))) (CC and) (NP (NP (NN efficiency)) (PP (IN of) (NP (JJ preventive) (NNS interventions))))))) (, ,) (NP (PDT such) (DT an) (NN A1C) (NN cut) (NN point)) (VP (MD should) (VP (VB balance) (NP (NP (DT the) (NNS costs)) (PP (IN of) (NP (`` ``) (NP (JJ false) (NNS negatives)) ('' '') (PRN (-LRB- -LRB-) (S (VP (VBG failing) (S (VP (TO to) (VP (VB identify) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG going) (S (VP (TO to) (VP (VB develop) (NP (NN diabetes))))))))))))))) (-RRB- -RRB-)))) (PP (IN against) (NP (NP (NP (DT the) (NNS costs)) (PP (IN of) (NP (`` ``) (NP (JJ false) (NNS positives)) ('' '')))) (PRN (-LRB- -LRB-) (PP (ADVP (RB falsely)) (S (VP (VP (VBG identifying)) (CC and) (VP (ADVP (RB then)) (VBG spending) (NP (NN intervention) (NNS resources)) (PP (IN on) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (RB not) (VP (VBG going) (S (VP (TO to) (VP (VB develop) (NP (NN diabetes)) (ADVP (RB anyway))))))))))))))) (-RRB- -RRB-))))))) (. .)))
(ROOT (S (SBAR (IN As) (S (VP (VBZ is) (NP (NP (DT the) (NN case)) (PP (IN with) (NP (DT the) (NN glucose) (NNS measures))))))) (, ,) (NP (NP (JJ several) (JJ prospective) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBD used) (NP (NN A1C)) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN progression)) (PP (TO to) (NP (NN diabetes))))))))))) (VP (VBD demonstrated) (NP (NP (DT a) (JJ strong) (, ,) (JJ continuous) (NN association)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (JJ subsequent) (NN diabetes)))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (NP (DT a) (JJ systematic) (NN review)) (PP (IN of) (NP (CD 44,203) (NNS individuals)))) (PP (IN from) (NP (NP (CD 16) (NN cohort)) (NNS studies))) (PP (IN with) (S (NP (DT a) (JJ follow-up) (NN interval)) (VP (VBG averaging) (NP (NP (CD 5.6) (NNS years)) (PRN (-LRB- -LRB-) (NP (NP (NN range) (CD 2.8)) (: --) (NP (CD 12) (NNS years))) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT those)) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN between) (NP (QP (CD 5.5) (CC and) (CD 6.0)) (NN %)))))) (VP (VBD had) (NP (NP (DT a) (ADJP (RB substantially) (VBN increased)) (NN risk)) (PP (IN of) (NP (NN diabetes))) (PP (IN with) (NP (NP (JJ 5-year) (NNS incidences)) (VP (VBG ranging) (PP (PP (IN from) (NP (CD 9))) (PP (TO to) (NP (CD 25) (NN %))))))))) (. .)))
(ROOT (S (NP (NP (DT An) (NN A1C) (NN range)) (PP (IN of) (NP (CD 6.0)))) (: --) (NP (ADJP (CD 6.5) (NN %))) (VP (VBD had) (NP (NP (DT a) (JJ 5-year) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NP (NN diabetes)) (PP (IN between) (NP (NP (CD 25) (CC and) (NP (CD 50) (NN %))) (CC and) (NP (JJ relative) (NN risk))))) (ADJP (QP (CD 20) (NNS times)) (JJR higher)))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (NP (CD 5.0) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (NP (DT a) (JJ community-based) (NN study)) (PP (IN of) (NP (ADJP (JJ black) (CC and) (JJ white)) (NNS adults)))) (PP (IN without) (NP (NN diabetes))))) (, ,) (NP (NN baseline) (NN A1C)) (VP (VBD was) (NP (NP (NP (DT a) (JJR stronger) (NN predictor)) (PP (IN of) (NP (NP (JJ subsequent) (NN diabetes)) (CC and) (NP (JJ cardiovascular) (NNS events))))) (SBAR (IN than) (S (VP (VBD was) (VP (VBG fasting) (NP (NN glucose) (-LRB- -LRB-) (CD 11) (-RRB- -RRB-)))))))) (. .)))
(ROOT (S (NP (JJ Other) (NNS analyses)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7) (NN %)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ similar) (NN diabetes) (NN risk)) (PP (TO to) (NP (NP (DT the) (JJ high-risk) (NNS participants)) (PP (IN in) (NP (DT the) (NN DPP) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))))))))))))) (. .)))
(ROOT (S (ADVP (RB Hence)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB consider) (NP (NP (NP (DT an) (NN A1C) (NN range)) (PP (IN of) (NP (CD 5.7)))) (PRN (: --) (NP (NP (CD 6.4) (NN %)) (PP (IN as) (S (VP (VBG identifying) (NP (NP (NNS individuals)) (PP (IN with) (NP (NP (JJ high) (NN risk)) (PP (IN for) (NP (JJ future) (NN diabetes)))))))))) (, ,))) (SBAR (WHPP (TO to) (WHNP (WP whom))) (S (NP (DT the) (NN term) (NNS prediabetes)) (VP (MD may) (VP (VB be) (VP (VBN applied))))))))))) (. .)))
(ROOT (NP (NP (NP (NP (NNS Individuals)) (PP (IN with) (NP (NP (DT an) (NN A1C)) (PP (IN of) (NP (CD 5.7)))))) (: --) (NP (NP (CD 6.4) (NN %)) (VP (MD should) (VP (VB be) (VP (VBN informed) (PP (PP (IN of) (NP (NP (PRP$ their) (VBN increased) (NN risk)) (PP (IN for) (NP (NN diabetes))))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ cardiovascular) (NN disease))))))) (CC and) (VP (VBD counseled) (PP (IN about) (NP (NP (JJ effective) (NNS strategies)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN weight) (NN loss)) (CC and) (NP (JJ physical) (NN activity)) (, ,) (SBAR (S (VP (TO to) (VP (VB lower) (NP (PRP$ their) (NNS risks)))))))))))) (. .)))
(ROOT (S (PP (IN As) (PP (IN with) (NP (NN glucose) (NNS measurements)))) (, ,) (NP (NP (DT the) (NN continuum)) (PP (IN of) (NP (NN risk)))) (VP (VBZ is) (ADJP (JJ curvilinear)) (, ,) (SBAR (IN so) (IN that) (S (PP (IN as) (NP (NN A1C) (NNS rises))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ rises) (ADVP (RB disproportionately)))))) (. .)))
(ROOT (S (ADVP (RB Accordingly)) (, ,) (NP (NNS interventions)) (VP (MD should) (VP (VB be) (NP (ADJP (RBS most) (JJ intensive) (CC and) (NN follow-up))))) (VP (MD should) (VP (VB be) (ADJP (RB particularly) (JJ vigilant)) (PP (IN for) (NP (NP (DT those)) (PP (IN with) (NP (NP (NN A1C) (NNS levels)) (ADVP (IN above) (NP (CD 6.0) (NN %))) (, ,) (SBAR (WHNP (WP who)) (S (VP (MD should) (VP (VB be) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (ADJP (RB very) (JJ high)) (NN risk))))))))))))))))) (. .)))
(ROOT (FRAG (ADVP (RB However)) (, ,) (SBAR (ADVP (RB just)) (IN as) (NP (NP (DT an) (JJ individual)) (PP (IN with) (NP (NP (NP (DT a) (NN fasting) (NN glucose)) (PP (IN of) (NP (CD 98) (NN mg/dl)))) (PRN (-LRB- -LRB-) (NP (CD 5.4) (NN mmol/l)) (-RRB- -RRB-))))) (S (VP (MD may) (RB not) (VP (VB be) (PP (IN at) (NP (NP (JJ negligible) (NN risk)) (PP (IN for) (NP (NN diabetes))))))) (, ,) (S (NP (NP (NP (NNS individuals)) (PP (IN with) (NP (NN A1C) (NNS levels)))) (PP (IN below) (NP (CD 5.7) (NN %)))) (VP (MD may) (ADVP (RB still)) (VP (VB be) (PP (IN at) (NP (NN risk))) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (NN level)) (PP (IN of) (NP (NP (NP (NN A1C)) (CC and) (NP (NN presence))) (PP (IN of) (NP (NP (JJ other) (NN risk) (NNS factors)) (, ,) (PP (JJ such) (IN as) (NP (NN obesity) (CC and) (NN family) (NN history))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NNP Committee)) (VP (VBD examined) (NP (NNS data)) (PP (IN from) (NP (NP (CD three) (JJ cross-sectional) (JJ epidemiologic) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD assessed) (NP (NP (NN retinopathy)) (PP (IN with) (NP (NP (NN fundus) (NN photography)) (CC or) (NP (JJ direct) (NN ophthalmoscopy)))))) (CC and) (VP (VBN measured) (NP (NP (NN glycemia)) (PP (IN as) (NP (NP (NNP FPG)) (, ,) (NP (JJ 2-h) (NN PG)) (, ,) (CC and) (NP (NN A1C)))))))))))) (. .)))
(ROOT (NP (NP (NNP Table) (CD 2) (NNS Categories)) (PP (IN of) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (NP (NP (NN diabetes)) (PRN (-LRB- -LRB-) (NP (NNS prediabetes)) (-RRB- -RRB-)))))) (S (X (SYM *)) (VP (SYM FPG) (NP (NP (NP (NP (NP (NP (CD 100) (NN mg/dl) (PRN (-LRB- -LRB-) (NP (CD 5.6) (NN mmol/l)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (CD 125) (NN mg/dl)) (PRN (-LRB- -LRB-) (NP (CD 6.9) (NN mmol/l)) (-RRB- -RRB-))))) (PRN (-LRB- -LSB-) (NP (NN IFG)) (-RRB- -RSB-))) (NP (NP (JJ 2-h) (NN PG)) (PP (IN in) (NP (NP (DT the) (JJ 75-g) (NN OGTT) (CD 140) (NN mg/dl)) (PRN (-LRB- -LRB-) (NP (CD 7.8) (NN mmol/l)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (CD 199) (NN mg/dl)) (PRN (-LRB- -LRB-) (NP (CD 11.0) (NN mmol/l)) (-RRB- -RRB-)))))) (PRN (-LRB- -LSB-) (NP (NNP IGT)) (-RRB- -RSB-))) (SBAR (S (NP (NP (NN A1C) (CD 5.7)) (: --) (NP (NP (ADJP (CD 6.4) (NN %)) (NN *)) (PP (IN For) (NP (DT all) (CD three) (NNS tests)))) (, ,) (NP (NN risk))) (VP (VBZ is) (ADJP (JJ continuous)) (, ,) (S (VP (VP (VBG extending) (PP (IN below) (NP (NP (DT the) (JJR lower) (NN limit)) (PP (IN of) (NP (DT the) (NN range)))))) (CC and) (VP (VBG becoming) (ADJP (RB disproportionately) (JJR greater) (PP (IN at) (NP (NP (JJR higher) (NNS ends)) (PP (IN of) (NP (DT the) (NN range))))))))))))))) (. .)))
(ROOT (S (NP (NN A1C)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB widely) (VBN used)) (NN marker)) (PP (IN of) (NP (JJ chronic) (NN glycemia)))) (, ,) (S (VP (VBG reflecting) (NP (JJ average) (NN blood) (NN glucose) (NNS levels)) (PP (IN over) (NP (NP (DT a) (JJ 2to) (JJ 3-month) (NN period)) (PP (IN of) (NP (NN time)))))))) (. .)))
(ROOT (S (NP (RB Prior) (NNP Expert) (NNS Committees)) (VP (VBP have) (RB not) (VP (VBN recommended) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT the) (NN A1C)) (PP (IN for) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))))))) (, ,) (PP (IN in) (NP (NN part))) (ADJP (JJ due) (PP (TO to) (NP (NP (NN lack)) (PP (IN of) (NP (NP (NN standardization)) (PP (IN of) (NP (DT the) (NN assay)))))))))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (NP (NN A1C) (NNS assays)) (VP (VBP are) (ADVP (RB now)) (ADJP (RB highly) (JJ standardized) (IN so)) (SBAR (IN that) (S (NP (PRP$ their) (NNS results)) (VP (MD can) (VP (VB be) (ADVP (RB uniformly)) (VP (VBN applied) (UCP (CC both) (ADVP (RB temporally)) (CC and)) (PP (IN across) (NP (NNS populations))))))))) (. .)))
(ROOT (S (S (PP (IN In) (NP (NP (PRP$ their) (JJ recent) (NN report)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-)))) (, ,) (NP (DT an) (NNP International) (NNP Expert) (NNP Committee)) (, ,) (PP (IN after) (NP (NP (DT an) (JJ extensive) (NN review)) (PP (IN of) (ADJP (DT both) (ADJP (JJ established)) (CC and) (VP (VBG emerging) (NP (JJ epidemiological) (NN evidence))))))) (, ,) (VP (VBD recommended) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN A1C) (NN test))) (VP (VP (TO to) (VP (VB diagnose) (NP (NN diabetes)) (, ,) (PP (IN with) (NP (NP (DT a) (NN threshold)) (PP (IN of) (NP (JJR >) (JJ =) (CD 6.5) (NN %))))))) (, ,) (CC and) (NP (NN ADA)))) (VP (VBZ affirms) (NP (DT this) (NN decision))))) (. .)))
(ROOT (S (NP (NP (DT The) (JJ diagnostic) (NN A1C) (NN cut) (NN point)) (PP (IN of) (NP (CD 6.5) (NN %)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN inflection) (NN point)) (PP (IN for) (NP (NN retinopathy) (NN prevalence)))))) (, ,) (SBAR (SINV (RB as) (VP (VBP are)) (NP (NP (DT the) (NP (JJ diagnostic) (NNS thresholds))) (PP (IN for) (NP (NP (NNP FPG) (CC and) (JJ 2-h) (NN PG)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-)))))))) (. .)))
(ROOT (S (NP (JJ Point-of-care) (NN A1C) (NNS assays)) (VP (VBP are) (RB not) (ADVP (RB sufficiently) (JJ accurate)) (S (PP (IN at) (NP (DT this) (NN time))) (S (VP (TO to) (VP (VB use) (PP (IN for) (NP (JJ diagnostic) (NNS purposes)))))))) (. .)))
(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT an) (JJ inherent) (NN logic)) (PP (TO to) (S (VP (VBG using) (NP (DT a) (ADJP (RBR more) (JJ chronic)) (CC versus) (NP (DT an) (JJ acute) (NN marker)) (PP (IN of) (NP (NN dysglycemia)))))))) (, ,) (SBAR (ADVP (RB particularly)) (IN since) (S (NP (DT the) (NN A1C)) (VP (VBZ is) (ADVP (RB already)) (ADJP (RB widely) (JJ familiar) (PP (TO to) (NP (NNS clinicians)))) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ glycemic) (NN control))))))))) (. .)))
(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (DT the) (NN A1C)) (VP (VP (VBZ has) (NP (NP (JJ several) (NNS advantages)) (PP (TO to) (NP (DT the) (NNP FPG)))) (, ,) (PP (VBG including) (NP (JJR greater) (NN convenience))) (, ,) (SBAR (IN since) (S (NP (NN fasting)) (VP (VBZ is) (RB not) (VP (VBN required)))))) (, ,) (NP (NP (NN evidence) (S (VP (TO to) (VP (VB suggest) (NP (JJR greater) (JJ preanalytical) (NN stability)))))) (, ,) (CC and) (NP (NP (ADJP (RBR less) (JJ day-to-day)) (NNS perturbations)) (PP (IN during) (NP (NP (NNS periods)) (PP (IN of) (NP (NP (NN stress)) (CC and) (NP (NN illness))))))))) (. .)))
(ROOT (S (NP (DT These) (NNS advantages)) (, ,) (ADVP (RB however)) (, ,) (VP (MD must) (VP (VB be) (VP (VBN balanced) (PP (IN by) (NP (JJR greater) (NN cost)))))) (, ,) (NP (NP (NP (DT the) (JJ limited) (NN availability)) (PP (IN of) (NP (NP (NN A1C) (NN testing)) (PP (IN in) (NP (NP (JJ certain) (NNS regions)) (PP (IN of) (NP (DT the) (VBG developing) (NN world)))))))) (, ,) (CC and) (NP (NP (DT the) (JJ incomplete) (NN correlation)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (NP (JJ average) (NN glucose)) (PP (IN in) (NP (JJ certain) (NNS individuals)))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NN A1C)) (VP (MD can) (VP (VB be) (ADJP (VBG misleading)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ certain) (NNS forms)) (PP (IN of) (NP (NN anemia) (CC and) (NP (NNS hemoglobinopathies)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (JJ unique) (ADJP (JJ ethnic) (CC or) (JJ geographic)) (NNS distributions)))))))))))))) (. .)))
(ROOT (FRAG (PP (IN For) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (DT a) (NN hemoglobinopathy)))) (CC but) (NP (JJ normal) (JJ red) (NN cell) (NN turnover)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ sickle) (NN cell) (NN trait)) (, ,) (NP (NP (DT an) (NN A1C) (NN assay)) (PP (IN without) (NP (NP (NN interference)) (PP (IN from) (NP (JJ abnormal) (NNS hemoglobins)))))) (VP (MD should) (VP (VB be) (VP (VBN used) (PRN (-LRB- -LRB-) (S (NP (DT an) (VBN updated) (NN list)) (VP (VBZ is) (ADJP (JJ available) (PP (IN at) (NP (NN http://www.ngsp.org/interf.asp)))))) (-RRB- -RRB-))))))))) (. .)))
(ROOT (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (PP (IN in) (NP (JJ such) (NNS cases))) (NP (DT the) (NN health) (NN care) (NN professional)) (VP (MD would) (ADVP (RB also)) (VP (VB measure) (NP (DT an) (NN A1C) (NN test)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (JJ initial) (NN assessment)) (PP (IN of) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NN diabetes)))))))))))))))) (CC and) (NP (SBAR (IN that) (S (NP (PRP it)) (VP (MD would) (PRN (-LRB- -LRB-) (PP (IN in) (NP (JJS most) (NNS cases))) (-RRB- -RRB-)) (VP (VB be) (PP (IN above) (NP (NP (DT the) (JJ diagnostic) (NN cut) (NN point)) (PP (IN for) (NP (NN diabetes)))))))))) (. .)))
(ROOT (FRAG (ADVP (RB However)) (, ,) (PP (IN in) (S (ADVP (RB rapidly)) (VP (VBG evolving) (NP (NP (NN diabetes)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN type) (CD 1) (NN diabetes))) (PP (IN in) (NP (DT some) (NNS children))))) (, ,) (NP (NN A1C))) (VP (MD may) (RB not) (VP (VB be) (ADJP (RB significantly) (JJ elevated)) (PP (IN despite) (NP (JJ frank) (NN diabetes)))))))) (. .)))
(ROOT (ADVP (RB Just) (SBAR (IN as) (S (NP (EX there)) (VP (VBZ is) (NP (NP (ADJP (QP (JJR less) (IN than) (CD 100)) (NN %)) (NN concordance)) (PP (IN between) (NP (DT the) (NNP FPG) (CC and) (JJ 2-h) (NN PG) (NNS tests))))))) (S (, ,) (NP (EX there)) (VP (VBZ is) (RB not) (NP (NP (JJ full) (NN concordance)) (PP (IN between) (NP (NP (NN A1C)) (CC and) (NP (CC either) (NP (JJ glucose-based) (NN test)))))))) (. .)))
(ROOT (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NNP NHANES) (NNS data)))) (VP (VBP indicate) (SBAR (IN that) (, ,) (S (S (VP (VBG assuming) (NP (NP (JJ universal) (NN screening)) (PP (IN of) (NP (DT the) (JJ undiagnosed)))))) (, ,) (NP (NP (DT the) (NN A1C) (NN cut) (NN point)) (PP (IN of) (NP (JJR >) (JJ =) (CD 6.5) (NN %)))) (VP (VBZ identifies) (NP (NP (NP (ADJP (JJ one-third) (JJR fewer)) (NNS cases)) (PP (IN of) (NP (JJ undiagnosed) (NN diabetes)))) (PP (IN than) (NP (NP (DT a) (NN fasting) (NN glucose) (NN cut) (NN point)) (PP (IN of) (NP (NP (NP (JJR >) (JJ =) (CD 126) (NN mg/dl)) (PRN (-LRB- -LRB-) (NP (CD 7.0) (NN mmol/l)) (-RRB- -RRB-))) (VP (-LRB- -LRB-) (NP (NP (JJ www.cdc.gov/diabetes/pubs/) (NN factsheet11/tables1) (NN _) (CD 2))))))))))))) (. .)))
(ROOT (FRAG (LST (NP (NN htm)) (-RRB- -RRB-)) (. .)))
(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP it)) (VP (VP (VBZ is) (ADJP (JJ conceivable) (SBAR (IN that) (S (NP (NP (DT the) (JJR lower) (NN sensitivity)) (PP (IN of) (NP (NN A1C))) (PP (IN at) (NP (DT the) (VBN designated) (NN cut) (NN point)))) (VP (MD will) (VP (VB be) (VP (VBN offset) (PP (IN by) (NP (NP (DT the) (NN test) (POS 's)) (JJR greater) (NN practicality)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (JJR wider) (NN application)) (PP (IN of) (NP (NP (DT a) (ADJP (RBR more) (JJ convenient)) (NN test)) (PRN (-LRB- -LRB-) (NP (NN A1C)) (-RRB- -RRB-))))) (VP (MD may) (ADVP (RB actually)) (VP (VB increase) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS diagnoses)) (VP (VBN made)))))))))) (. .)))
(ROOT (S (NP (JJ Further) (NN research)) (VP (VBZ is) (VP (VBN needed) (S (VP (TO to) (ADVP (RB better)) (VP (VB characterize) (NP (NP (DT those) (NNS patients)) (SBAR (WHNP (WP$ whose) (JJ glycemic) (NN status)) (S (VP (MD might) (VP (VB be) (VP (VBN categorized) (ADVP (RB differently)) (PP (IN by) (NP (NP (NP (CD two) (JJ different) (NNS tests)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (, ,) (NNP FPG) (CC and) (NN A1C)) (-RRB- -RRB-))) (, ,) (VP (VBN obtained) (PP (IN in) (NP (JJ close) (JJ temporal) (NN approximation))))))))))))))))) (. .)))
(ROOT (S (NP (JJ Such) (NN discordance)) (VP (MD may) (VP (VB arise) (PP (IN from) (NP (NP (NN measurement) (NN variability)) (, ,) (NP (NP (NN change)) (PP (IN over) (NP (NN time)))) (, ,) (CC or) (ADVP (IN because) (NP (NP (NP (NN A1C)) (, ,) (NP (NNP FPG)) (, ,) (CC and) (NP (NN postchallenge) (NN glucose))) (NP (DT each) (NN measure) (JJ different) (JJ physiological) (NNS processes)))))))) (. .)))
(ROOT (S (PP (IN In) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (DT an) (JJ elevated) (NN A1C))))) (NP (CC but) (NP (`` ``) (JJ nondiabetic) ('' '') (NNP FPG)) (, ,) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (JJR greater) (JJ postprandial) (NN glucose) (NNS levels)))) (CC or) (NP (NP (VBN increased) (NN glycation) (NNS rates)) (PP (IN for) (NP (NP (DT a) (VBN given) (NN degree)) (PP (IN of) (NP (NN hyperglycemia))))))) (VP (MD may) (VP (VB be) (ADJP (JJ present)))) (. .)))
(ROOT (S (PP (IN In) (NP (DT the) (JJ opposite) (NN scenario))) (PRN (-LRB- -LRB-) (NP (NP (JJ high) (NNP FPG)) (ADVP (RB yet)) (NP (NP (NN A1C)) (PP (IN below) (NP (DT the) (NN diabetes) (NN cut) (NN point))))) (-RRB- -RRB-)) (, ,) (VP (VBD augmented) (SBAR (S (NP (NP (JJ hepatic) (NN glucose) (NN production)) (CC or) (NP (VBN reduced) (NN glycation) (NNS rates))) (VP (MD may) (VP (VB be) (ADJP (JJ present))))))) (. .)))
(ROOT (S (PP (IN For) (NP (NN example))) (, ,) (SBAR (IN if) (S (S (NP (DT the) (NN A1C)) (VP (VBZ is) (NP (CD 7.0) (NN %)))) (CC and) (S (NP (DT a) (NN repeat) (NN result)) (VP (VBZ is) (NP (CD 6.8) (NN %)))))) (, ,) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes)))) (VP (VBZ is) (VP (VBN confirmed))) (. .)))
(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (NNS scenarios)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (VBZ results) (IN of) (NP (CD two) (JJ different) (NNS tests)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (PRN (, ,) (NP (NP (NNP FPG)) (CC and) (NP (NN A1C))) (-RRB- -RRB-))) (VP (VBP are) (ADJP (JJ available)) (PP (IN for) (NP (DT the) (JJ same) (NN patient)))))))) (. .)))
(ROOT (SINV (S (NP (DT That)) (VP (VBZ is))) (, ,) (SBAR (IN if) (S (S (NP (DT a) (NN patient)) (VP (VBZ meets) (NP (NP (DT the) (NN diabetes) (NN criterion)) (PP (IN of) (NP (NP (DT the) (NN A1C)) (PRN (-LRB- -LRB-) (S (NP (CD two) (NNS results)) (NP (JJR >) (JJ =) (CD 6.5) (NN %))) (-RRB- -RRB-))))))) (CC but) (NP (NP (RB not) (DT the) (NNP FPG) (PRN (-LRB- -LRB-) (NP (CD ,126) (NN mg/dl) (CC or) (CD 7.0) (NN mmol/l)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN vice) (RB versa) (, ,) (SBAR (IN that) (S (NP (NN person)) (VP (MD should) (VP (VB be) (VP (VBN considered) (S (VP (TO to) (VP (VB have) (NP (NN diabetes)))))))))))))) (. .)))
(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (RBS least) (JJ likely) (PP (IN for) (NP (NN A1C)))) (, ,) (ADJP (RB somewhat) (ADJP (RBR more) (JJ likely) (PP (IN for) (NP (NNP FPG)))) (, ,) (CC and) (ADJP (RBS most) (JJ likely))) (PP (IN for) (NP (DT the) (JJ 2-h) (NN PG)))) (. .)))
(ROOT (NP (NP (NP (NNP Table) (CD 3) (NNP Criteria)) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NP (NN diabetes) (NN A1C)) (JJR >) (JJ =) (CD 6.5) (NN %)))))) (. .)))
(ROOT (NP (NP (NNP International) (NNP Expert) (NNP Committee) (NN report)) (PP (IN on) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NN A1C) (NN assay))) (PP (IN in) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NN diabetes))))))) (. .)))
(ROOT (S (S (NP (NP (VBN Combined) (NN measurement)) (PP (IN of) (S (VP (VBG fasting) (NP (NP (NN plasma) (NN glucose)) (CC and) (NP (NN A1C))))))) (VP (VBZ is) (ADJP (JJ effective) (PP (IN for) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (NN type) (CD 2) (NN diabetes)))))))) (: :) (NP (DT the) (NNP Kansai) (NNP Healthcare) (NNP Study)) (. .)))
(ROOT (NP (CD 10) (. .)))
(ROOT (NP (NP (NP (NNP Zhang) (NNP X)) (, ,) (NP (NNP Gregg) (NNP EW)) (, ,) (NP (NNP Williamson) (NNP DF)) (, ,) (NP (NNP Barker) (NNP LE)) (, ,) (NP (NNP Thomas) (NNP W)) (, ,) (NP (NNP Bullard) (NNP KW)) (, ,) (NP (NNP Imperatore) (NNP G)) (, ,)) (NP (NP (NNP Williams) (NN DE)) (, ,) (NP (NNP Albright) (NNP AL.))) (. .)))
(ROOT (NP (NP (NP (NP (NN A1C) (NN level)) (CC and) (NP (NP (JJ future) (NN risk)) (PP (IN of) (NP (NN diabetes))))) (: :) (NP (DT a) (JJ systematic) (NN review))) (. .)))
(ROOT (S (NP (DT A) (NN management) (NN plan) (S (VP (TO to) (VP (VB achieve) (NP (ADJP (ADJP (JJ normal)) (CC or) (ADJP (JJ near-normal))) (NN glycemia)) (PP (IN with) (NP (NP (DT an) (NN A1C) (NN goal)) (PP (IN of) (NP (CD ,7) (NN %))))))))) (VP (MD should) (VP (VB be) (VP (VBN developed) (PP (IN for) (NP (NP (NN diabetes) (NN management)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (JJ initial) (JJ medical) (NN evaluation)))))))))) (. .)))
(ROOT (NP (NP (NNP Table) (CD 1) (NNP Summary)) (PP (IN of) (NP (NP (NNS recommendations)) (PP (IN for) (ADJP (ADJP (JJ glycemic)) (, ,) (NP (NP (NN blood) (NN pressure)) (, ,) (CC and) (NP (NP (NN lipid) (NN control)) (PP (IN for) (NP (JJS most) (NNS adults)))) (PP (IN with) (S (NP (NP (NN diabetes) (NN A1C)) (NP (ADJP (QP (JJR <) (CD 7.0)) (NN %)) (NN *) (NN Blood) (NN pressure))) (VP (JJR <) (NP (NP (QP (CD 140/80)) (NN mmHg) (CD †) (NNS Lipids)) (SBAR (S (NP (NP (JJR <) (CD 100) (NN mg/dL) (NN LDL) (NN cholesterol)) (PRN (-LRB- -LRB-) (ADJP (JJR <) (NP (QP (CD 2.6)) (NN mmol/L))) (-RRB- -RRB-))) (VP (CD ‡) (SBAR (X (SYM *)) (ADVP (RBR More) (CC or) (S (NP (ADJP (RBR less) (JJ stringent)) (JJ glycemic) (NNS goals)) (VP (MD may) (VP (VB be) (ADJP (JJ appropriate) (PP (IN for) (NP (JJ individual) (NNS patients))))))))))))))))))))) (. .)))
(ROOT (S (NP (VBN Glycated) (NP (NP (NN hemoglobin)) (PRN (-LRB- -LRB-) (NP (NN A1C)) (-RRB- -RRB-)))) (VP (VBZ is) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (JJ long-term) (-LRB- -LRB-) (JJ 2to) (FRAG (ADJP (JJ 3-month))) (-RRB- -RRB-) (JJ glycemic) (NN control))))) (. .)))
(ROOT (S (S (VP (VB Perform) (NP (DT the) (NN A1C) (NN test)) (NP (NP (ADVP (IN at) (JJS least)) (NP (NP (CD two) (NNS times)) (NP (DT a) (NN year))) (PP (IN in) (NP (NNS patients)))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (NP (NP (NN meeting) (NN treatment) (NNS goals)) (-LRB- -LRB-) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (JJ stable) (JJ glycemic) (NN control)))))))))))) (-RRB- -RRB-) (CC and) (NP (ADJP (JJ quarterly) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP$ whose) (NN therapy)) (S (VP (VBZ has) (VP (VBN changed)))))))) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBP are) (RB not) (VP (VBG meeting) (NP (JJ glycemic) (NNS goals))))))) (. .)))
(ROOT (S (NP (NP (NNS Discrepancies)) (PP (IN between) (NP (NP (NNP CBG)) (VP (VBG monitoring) (NP (NNS results) (CC and) (NN A1C)))))) (VP (MD may) (VP (VB indicate) (NP (NP (DT a) (NN hemoglobinopathy)) (, ,) (NP (NN hemolysis)) (, ,) (CC or) (VP (VP (VB need) (PP (IN for) (NP (NP (NN evaluation)) (PP (IN of) (NP (NP (NP (NP (NN CBG) (NN monitoring) (NN technique)) (CC and) (NP (NN equipment))) (CC or) (NP (NN initiation))) (PP (IN of) (NP (NP (ADJP (JJR more) (JJ frequent)) (NN CBG)) (VP (VBG monitoring) (S (VP (TO to) (VP (VB identify) (SBAR (WHADVP (WRB when)) (S (NP (JJ glycemic) (NNS excursions)) (VP (VBP are) (VP (VBG occurring)))))))))))))))) (CC and) (SBAR (WHNP (WHNP (WDT which) (NN facet)) (PP (IN of) (NP (DT the) (NN diabetes) (NN regimen)))) (S (VP (VBZ is) (VP (VBG changing))))))))) (. .)))
(ROOT (S (NP (NN •) (NN A1C)) (VP (MD should) (VP (VB be) (VP (VBN checked) (NP (NP (DT every) (CD 3)) (: --) (NP (CD 6) (NNS months)))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (PP (IN At) (NP (DT a) (NN minimum))) (, ,) (NP (DT the) (NN summary)) (VP (MD should) (VP (VB include) (NP (NP (DT the) (NN following)) (: :) (S (S (VP (VB •) (NP (NP (NP (DT the) (NN patient) (POS 's)) (JJ current) (NN medication) (NN schedule)) (CC and) (NP (NNS dosages))))) (VP (VBP •) (NP (NP (DT the) (NN date)) (CC and) (NP (NP (NN time)) (PP (IN of) (NP (NP (DT the) (JJ last) (NN medication) (NN administration)) (NP (CD •)))))) (NP (NP (DT any) (NP (JJ recent) (NN monitoring) (NNS results)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (, ,) (NP (NNP CBG)) (CC and) (NP (NN A1C))) (-RRB- -RRB-))) (NP (NP (CD •) (JJ other) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP indicate) (NP (NP (DT a) (NN need)) (PP (IN for) (NP (NP (JJ immediate) (NN treatment) (CC or) (NN management)) (SBAR (IN at) (FRAG (NP (DT the) (VBG receiving) (NN facility)) (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (PRN (, ,) (NP (NP (NP (JJ recent) (NNS episodes)) (PP (IN of) (NP (NN hypoglycemia)))) (, ,) (NP (NP (NN history)) (PP (IN of) (NP (NP (JJ severe) (NN hypoglycemia)) (CC or) (NP (JJ frequent) (NN DKA))))) (, ,) (NP (JJ concurrent) (NNS illnesses)) (, ,) (NP (NP (NN presence)) (PP (IN of) (NP (NN diabetes) (NNS complications))))) (-RRB- -RRB-)) (NP (NP (CD •) (NN information)) (PP (IN on) (NP (NP (JJ scheduled) (NN treatment)) (ADJP (: /) (SBAR (S (NP (NP (NNS appointments)) (SBAR (IN if) (S (NP (DT the) (VBG receiving) (NN facility)) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG transporting) (NP (DT the) (NN patient)) (PP (TO to) (NP (DT that) (NP (NN appointment) (CD •) (NN name)) (CC and) (NP (NP (NN telephone/fax) (NN number)) (PP (IN of) (NP (DT a) (NN contact) (NN person)))))) (PP (IN at) (NP (NP (DT the) (VBG transferring) (NN facility)) (SBAR (WHNP (WP who)) (S (VP (MD can) (VP (VB provide) (NP (JJ additional) (NN information)) (, ,) (SBAR (IN if) (S (VP (VBN needed) (NP (NP (DT The) (JJ medical) (NN transfer) (NN summary)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ quick) (JJ medical) (NN reference)) (PP (IN for) (NP (DT the) (VBG receiving) (NN facility)))))))) (, ,))))))))))))))))))) (VP (MD should) (VP (VB be) (VP (VBN transferred) (ADVP (IN along) (PP (IN with) (NP (DT the) (NN patient))))))))))))))))))))))))))))) (. .)))
(ROOT (S (NP (DT The) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN provided) (PP (IN with) (NP (NP (DT a) (VBN written) (NN summary)) (PP (IN of) (NP (NN his/her) (JJ current) (NN health) (NN care) (NNS issues))) (, ,) (PP (VBG including) (NP (NP (NNS medications) (CC and) (NNS doses)) (, ,) (NP (JJ recent) (NN A1C) (NNS values)) (, ,) (FW etc.)))))))) (. .)))
(ROOT (S (NP (NP (NNS Recommendations) (NN •)) (PP (IN For) (NP (DT all) (JJ interinstitutional) (NNS transfers))) (, ,)) (VP (VB complete) (NP (DT a) (JJ medical) (NN transfer) (NN summary)) (S (VP (TO to) (VP (VB be) (VP (VBN transferred) (PP (IN with) (NP (DT the) (NN patient)))))))) (. .)))
(ROOT (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-)))
(ROOT (S (S (NP (DT The) (NNS data)) (VP (VBN needed) (VP (MD will) (VP (VB vary) (PP (VBG depending) (PP (PP (IN on) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NN job))))) (CC and) (NP (NP (DT the) (NN reason)) (PP (IN for) (NP (DT the) (NN evaluation)))))))))) (, ,) (CC but) (S (NP (DT an) (NN evaluation)) (VP (MD should) (ADVP (RB never)) (VP (VB be) (VP (VBN made) (S (VP (VBN based) (PP (RB only) (IN on) (NP (NP (CD one) (NN piece)) (PP (IN of) (NP (NNS data) (, ,) (ADJP (JJ such) (SBAR (IN as) (S (NP (NP (DT a) (JJ single) (NN blood) (NN glucose)) (VP (VBP result) (CC or) (NP (NN A1C)))) (VP (VBP result))))))))))))))) (. .)))
(ROOT (NP (NP (NP (NN A1C)) (CC and) (NP (VBN estimated) (JJ average) (NN glucose))) (. .)))
(ROOT (S (NP (NP (NP (NN Hemoglobin) (NN A1C)) (PRN (-LRB- -LRB-) (NP (NN A1C)) (-RRB- -RRB-))) (NN test)) (VP (VBZ results) (VP (VBP reflect) (NP (NP (JJ average) (NN glycemia)) (PP (IN over) (NP (JJ several) (NNS months))))) (CC and) (VP (VBP correlate) (PP (IN with) (NP (NP (JJ mean) (NN plasma) (NN glucose) (NNS levels)) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-)))))) (. .)))
(ROOT (S (S (VP (VBN Estimated) (S (S (NP (NP (JJ average) (NN glucose)) (PRN (-LRB- -LRB-) (NP (NN eAG)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (RB directly) (JJ related) (PP (TO to) (NP (NN A1C)))))) (CC and) (S (ADVP (RB also)) (VP (VBZ provides) (NP (DT an) (JJ individual)) (PP (IN with) (NP (NP (NP (DT an) (NN estimate)) (PP (IN of) (NP (JJ average) (NN blood) (NN glucose)))) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (NN time)))))))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ uses) (NP (NP (DT the) (JJ same) (NNS values) (CC and) (NNS units)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (DT a) (NN glucose) (NN meter)) (CC or) (VP (VBG recording) (NP (DT a) (NN fasting) (NN glucose) (NN value)) (PP (IN on) (NP (NP (DT a) (NN lab) (NN report)) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-)))))))))))))))) (. .)))
(ROOT (S (NP (NN A1C/eAG) (NNS values)) (VP (VP (VBP provide) (NP (NN health) (NN care) (NNS providers)) (PP (IN with) (NP (NP (JJ important) (NN information)) (PP (IN about) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (NP (DT an) (NN individual) (POS 's)) (NN treatment) (NN regimen)) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-))))))))) (CC but) (VP (VBP are) (ADVP (RB often)) (VP (VBN misused) (PP (IN in) (S (VP (VBG assessing) (SBAR (IN whether) (S (NP (NP (DT an) (JJ individual) (CD •)) (SBAR (DT an) (S (RB safely) (VP (VB perform) (NP (DT a) (NN job)))))))))))))) (. .)))
(ROOT (SBAR (IN Because) (S (NP (PRP they)) (VP (VBP identify) (NP (NP (RB only) (NNS averages)) (CC and) (S (RB not) (SBAR (IN whether) (S (NP (DT the) (NN person)) (VP (VBD had) (NP (JJ severe) (JJ extreme) (NN blood) (NN glucose) (NNS readings))))) (, ,) (NP (NN A1C/eAG) (NNS results)) (VP (VP (VBP are) (PP (IN of) (NP (DT no) (NN value))) (PP (IN in) (S (VP (VBG predicting) (NP (NP (JJ short-term) (NNS complications)) (PP (IN of) (NP (NN diabetes)))))))) (CC and) (RB thus) (VP (VBP have) (NP (DT no) (NN use)) (PP (IN in) (S (VP (VBG evaluating) (NP (NP (NNS individuals)) (PP (IN in) (NP (NN employment) (NNS situations))))))))))))) (. .)))
(ROOT (S (NP (DT The) (JJ American) (NNP Diabetes) (NNP Association)) (VP (VBZ recommends) (SBAR (IN that) (S (PP (IN in) (NP (JJS most) (NNS patients))) (NP (NN A1C) (NNS levels)) (VP (VB be) (VP (VBN kept) (PP (IN below) (PP (NP (NP (NP (CD 7) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 4)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN eAG))) (IN below) (NP (CD 154) (NN mg/dL))))))))) (. .)))
(ROOT (S (NP (DT An) (NN A1C) (CC or) (NN eAG)) (VP (VP (VBD cut) (PRT (RP off)) (SBAR (S (NP (NN score)) (VP (VBZ is) (RB not) (ADJP (RB medically) (JJ justified) (PP (IN in) (NP (NN employment) (NNS evaluations)))))))) (CC and) (VP (MD should) (ADVP (RB never)) (VP (VB be) (NP (NP (DT a) (JJ determinative) (NN factor)) (PP (IN in) (NP (NN employment))))))) (. .)))
(ROOT (LST (CD 5) (. .)))
(ROOT (NP (NP (NP (NNP Nathan) (NN DM)) (, ,) (NP (NN Kuenen) (NN J)) (, ,) (NP (NNP Borg) (NNP R)) (, ,) (NP (NNP Zheng) (NNP H)) (, ,) (NP (NP (NNP Schoenfeld) (NNP D)) (, ,) (NP (NP (NNP Heine) (NN R)) (: :) (S (VP (VBG Translating) (NP (DT the) (NN A1C) (NN assay)) (PP (IN into) (NP (VBN estimated) (JJ average) (NN glucose) (NNS values)))))))) (. .)))
(ROOT (S (NP (NP (DT The) (NNS ABCs)) (PP (IN of) (NP (NN diabetes)))) (: :) (NP (NP (NN diabetes) (NN self-management) (NN education) (NN program)) (PP (IN for) (NP (JJ African) (NNPS Americans)))) (VP (VBZ affects) (NP (NP (NN A1C)) (, ,) (NP (JJ lipid-lowering) (NN agent) (NNS prescriptions)) (, ,) (CC and) (NP (NN emergency) (NN department) (NNS visits)))) (. .)))
(ROOT (NP (NP (NN EXPERT) (NNP COMMITTEE) (NNS REPORTS) (NNP International) (NNP Expert) (NNP Committee) (NNP Report)) (PP (IN on) (NP (NP (DT the) (NN Role)) (PP (IN of) (NP (DT the) (NN A1C) (NN Assay))))) (PP (IN in) (NP (NP (DT the) (NN Diagnosis)) (PP (IN of) (NP (NP (NNP Diabetes) (NNP International) (NNP Expert) (NNP Committee) (NNP Diabetes) (NNP Care) (CD 32:1327)) (: --) (NP (NP (NP (CD 1334)) (, ,) (NP (NP (QP (CD 2009) (CD •))) (NP (NNP ONSENSUS) (NNS REPORTS) (NNP Diabetes)))) (PP (IN in) (NP (NNP Older) (NNS Adults) (NN M.))))))))))